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Tau Interdomain Relationships: Re-Examining The Role Of The Proline Rich
Region In Tau's Structure And Function In Vitro
Abstract
Tau is an intrinsically disordered (IDP), microtubule-associated (MAP) protein that has a role in regulating
microtubule dynamics. Despite intensive research, the molecular mechanisms of tau-mediated
microtubule polymerization are poorly understood. In particular, although significant effort has poured
into interactions between the microtubule protofilament and one of tau’s regions, the microtubule-binding
region (MTBR), the remaining tau domains and interactions with unincorporated soluble tubulin remain
understudied. Here, we used single-molecule fluorescence to investigate the role of tau’s N-terminal
domain (NTD) and proline-rich region (PRR) in regulating interactions of tau with soluble tubulin. We
assayed both full-length tau isoforms and truncated variants for their ability to bind soluble tubulin and
stimulate microtubule polymerization. We found that tau’s PRR is an independent tubulin-binding domain
that has tubulin polymerization capacity. In contrast to the relatively weak interactions with tubulin
mediated by sites distributed throughout tau’s MTBR, resulting in heterogeneous tau:tubulin complexes,
the PRR bound tubulin tightly and stoichiometrically. Moreover, we demonstrate that interactions between
the PRR and MTBR are reduced by the NTD through a conserved conformational ensemble. On the basis
of these results, we propose that tau’s PRR can serve as a core tubulin-binding domain, whereas the
MTBR enhances polymerization capacity by increasing the local tubulin concentration. Moreover, the NTD
appears to negatively regulate tubulin-binding interactions of both of these domains. The findings of our
study draw attention to a central role for the PRR in tau function and provide mechanistic insight into taumediated polymerization of tubulin. However, PRR binding was not observed in the recent cryo-EM
structure of tau’s MTBR bound to the microtubule protofilament (Nogales, 2018). Using an
environmentally sensitive fluorophore acrylodan, we demonstrate similarities between tau’s MTBR
structure to soluble tubulin and the microtubule. Our preliminary work suggests PRR binding to tubulin is
strongly mediated through the tubulin tails. In summary, this thesis provides mechanistic and structural
insight into tau-mediated microtubule polymerization by (1) clarifying the role of tau’s PRR thereby refining
polymerization models (2) demonstrating a conserved ensemble between the NTD and the PRR/MTBR
regions of functional significance, and (3) outlining preliminary groundwork for contrasting taumicrotubule and tau-tubulin interactions.
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ABSTRACT
TAU INTERDOMAIN RELATIONSHIPS: RE-EXAMINING THE ROLE OF PRR
IN TAU’S STRUCTURE AND FUNCTION IN VITRO

Kristen May McKibben
Elizabeth Rhoades

Tau is an intrinsically disordered (IDP), microtubule-associated (MAP) protein
that has a role in regulating microtubule dynamics. Despite intensive research, the
molecular mechanisms of tau-mediated microtubule polymerization are poorly
understood. In particular, although significant effort has poured into interactions between
the microtubule protofilament and one of tau’s regions, the microtubule-binding region
(MTBR), the remaining tau domains and interactions with unincorporated soluble tubulin
remain understudied. Here, we used single-molecule fluorescence to investigate the role
of tau’s N-terminal domain (NTD) and proline-rich region (PRR) in regulating
interactions of tau with soluble tubulin. We assayed both full-length tau isoforms and
truncated variants for their ability to bind soluble tubulin and stimulate microtubule
polymerization. We found that tau’s PRR is an independent tubulin-binding domain that
has tubulin polymerization capacity. In contrast to the relatively weak interactions with
tubulin mediated by sites distributed throughout tau’s MTBR, resulting in heterogeneous
tau:tubulin complexes, the PRR bound tubulin tightly and stoichiometrically. Moreover,
we demonstrate that interactions between the PRR and MTBR are reduced by the NTD
8
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through a conserved conformational ensemble. On the basis of these results, we propose
that tau’s PRR can serve as a core tubulin-binding domain, whereas the MTBR enhances
polymerization capacity by increasing the local tubulin concentration. Moreover, the
NTD appears to negatively regulate tubulin-binding interactions of both of these
domains. The findings of our study draw attention to a central role for the PRR in tau
function and provide mechanistic insight into tau-mediated polymerization of tubulin.
However, PRR binding was not observed in the recent cryo-EM structure of tau’s MTBR
bound to the microtubule protofilament (1). Using an environmentally sensitive
fluorophore acrylodan, we demonstrate similarities between tau’s MTBR structure to
soluble tubulin and the microtubule. Our preliminary work suggests PRR binding to
tubulin is strongly mediated through the tubulin tails. In summary, this thesis provides
mechanistic and structural insight into tau-mediated microtubule polymerization by (1)
clarifying the role of tau’s PRR thereby refining polymerization models (2)
demonstrating a conserved ensemble between the NTD and the PRR/MTBR regions of
functional significance, and (3) outlining preliminary groundwork for contrasting taumicrotubule and tau-tubulin interactions.
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CHAPTER 1: Introduction
In 1975 the non-motor microtubule associated protein (MAP) tau was
biophysically characterized as lacking a stable secondary or tertiary structure (2).
Academic focus on tau increased upon its use as a biomarker for a class of
neurodegenerative diseases known as tauopathies that include both Alzheimer’s and
Parkinson’s disease (3). In 2018, an estimated 5.7 million Americans in 2018 suffered
from Alzheimer’s disease, and this number is expected to rise (4); effective therapeutics
to treat these diseases are critical not only for the suffers but also their caregivers whose
uncompensated care totals an estimated $232 billion a year (4). Due to ongoing yet
faltering efforts with other cellular targets for therapeutics, tau is now a primary
candidate for pharmaceutical research. Despite renewed scientific vigor, remarkably
basic scientific questions regarding tau’s functions within the cell remain unanswered or
debated. Presented here is an expanded study on the oldest proposed function of tau –
microtubule polymerization – and the regions that govern it including regulatory
mechanisms and corresponding initial coarse-grained structural characterization.
Combined, these studies provide additional mechanistic insight into tau-mediated
polymerization of microtubules with implications for tau’s ability to decipher the tubulin
‘code.’
Tauopathies
Tau is primarily located in the axons of neurons within the brain and central
nervous system (reviewed in (5)). In the diseased brain, tau forms proteinacious plaques
called paired helical filaments and neurofibrillary tangles – the particularly prominent
1

features of these diseases (6). The amyloid hypothesis suggests amyloid-beta (Aβ) was
the underlying component of amyloidgenesis that is influenced by additional interactions
with tau (7). However, tau alone is the predominate biomarker in other neurodegenerative
diseases such as frontotemporal dementia and Parkinsonism linked to chromosome-17
(8). Consequently, tau has been implicated in both gain-in-toxicity as well as loss-offunction disease mechanisms (9). The former primarily arises from the amyloid
hypothesis: hyperphosphorylation of tau leads to the sequestration of normal tau as well
as other MAPs eventually leading to toxic and transmittable oligomers and large
aggregated protein plaques that interfere with normal function (7). Less studied are lossof-function disease mechanisms. Indeed, two of tau’s biological roles are regulating
microtubule dynamics and cellular-transport primarily by modulating the progress of
molecular motors along the axon (2, 10-13); arguably, healthy biological function within
neurons is therefore dependent upon normal tau function.
Microtubules
Microtubules are a cornerstone of the cytoskeleton that provide structural support,
and play a role in cellular organization, chromosomal segregation during mitosis, cellular
transport, and cell force generation and movement (14, 15). Within neurons, they are
nicknamed the ‘highway of the cell’ along which cellular cargo is transported (13).
Microtubules are polymers of heterodimers of α and β tubulin, which are the focus of this
thesis. Heterodimeric α/β tubulin subunits assemble into protofilaments in a guanosine5’-triphosphate (GTP) hydrolysis dependent manner end-to-end such that each β subunit
of one heterodimer is docked against the α subunit of next tubulin heterodimer subunit
8
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(16, 17). This polarity of growth is further indicated by (-) and (+) ends such that α(-) is
the slow growing end, and β(+) is the positive growing end. Multiple protofilaments are
then ‘zipped’ together to form a microtubule (18). Most in vivo mirotubules consist of 13
protofilaments, although protofilament numbers vary in vivo (19) and are manipulated in
vitro by MAPs (20, 21).
As previously alluded, microtubules undergo cycles of growth and shrinkage
phases triggered by rescue and catastrophe events collectively referred to as ‘dynamic
instability’ as first described by Mitchison and Kirschner (22). The characteristic
parameters of these events are: growth rate, shrinkage rate, and catastrophe frequency and
rescue frequency. Microtubules also ‘pause’ and there appears to be very little length
change in the microtubule (22, 23). Simplistically, the growth happens predominately at
the β (+) end by incorporating GTP-tubulin at the microtubule tip. Sufficiently high rates
of incorporation lead to the ‘GTP-cap’ composed of multiple GTP-tubulin subunits (22,
24). Recent studies suggest incoming GTP-tubulin is incorporated as a tapered sheet that
is zippered up into the hollow microtubule tube (18). As new tubulin heterodimers are
incorporated, the previously incorporated subunit becomes hydrolytically competent
eventually becoming GDP-tubulin. While GTP-tubulin is straight, GDP-tubulin is curved
in solution and therefore introduces strain on the microtubule lattice (25-27). Once the
GTP-cap is lost, microtubules peel away as curved protofilaments (28-30).
Tubulin isotypes and the ‘tubulin code’
As previously mentioned, α(-) and β(+) tubulin form one heterodimeric tubulin
unit. As with all tubulins, they are highly conserved across species. In higher eurkayotes,
8
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multiple tubulin gene families give rise to tubulin isotypes (31, 32). For example, within
humans there are 8 α(-) and 9 β(+) tubulin isotypes (33, 34). Tubulin isotypes are 90%
homologous in both amino acid sequence and structure, varying predominately in the
intrinsically disordered C-terminal tails (35). Tubulin heterogeneity is generally referred
to as a ‘mosaicism’, and is an active area of research (32). The precise tubulin isotype and
its relative ratio of the tubulin pool vary across each organism and cell type with neurons
generally having the highest complexity (33, 36). Interestingly, functional specialization
in vivo and differences in microtubule dynamics in vitro have been demonstrated in a
small set of systems (13, 37). Whether these functional differences come from the very
subtle structural differences within the tubulin body (37) or other mechanisms involving
the more variable tubulin tail, or a combination of both the tubulin body structure and the
variable tail, is unknown. More concretely, mutations result in serious diseases, not all of
which are neurological (32). For example, while mutations in the beta tubulin isotypes 2B
and 3 (TubB2B and TubB3 respectively) and alpha tubulin isotype 1A (TubA1A) have
similar neurodegenerative phenotypes (32), defects in beta tubulin isotype 8 (TubB8)
uniquely and exclusively result in female sterility (38). Additionally, tubulin isotype
expression is both temporally and spatially controlled (35, 36, 39). This has led to the
proposition that the degree of mosaicism within the microtubule lattice may be precisely
regulated determining a variety of cellular functions including axonal transport and cell
differentiation (13, 32). Layered on top of the isotype are post-translational modifications
(PTMs) to the C-terminal tail including: glutamylation, polyglutamation, tyrosination,
glycylation, polyglycylation, and enzymatic digestion (40). Again, the PTMs are spatially
8
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specific and impact a variety of microtubule and MAP associated functions (13, 32, 40).
In particular, axons are rich in glutamylated tubulin which increases tau’s affinity for
tubulin (41), however, as the chain length of subsequent polyglutamation increases tau
binding decreases (42). In summary, the tubulin isotype mosaic, modifying PTMs, and
the degree of strain or compaction along the microtubule lattice has been termed the
‘tubulin code’, and is an active area of research with implications in axonogenesis, axonal
transport, cell signaling, and developmental biology.
Tau-tubulin interactions and tau-mediated microtubule dynamics
Tau belongs to a family of non-motor microtubule-associated proteins (MAPs)
that generally function to modulate microtubule stability and dynamics, as well as
regulate the transport cellular cargo. Of this group, tau is seen as a microtubule stabilizer
(43). Specifically, tau does this by three major mechanisms: (1) suppression of
catastrophe frequency, (2) reducing the length (in time) of both growing and shortening
events, and (3) increased polymerization at both α(-) and β(+) microtubule polarities (2,
44-46). Tau’s location along the microtubule is debated with multiple diffusion models
(47-49). Additionally, tau has been proposed to bind preferentially to either GDP-tubulin
or GTP-tubulin, although both tau’s preferred binding partner (GDP-tubulin or GTPtubulin) as well as the its discriminatory power between the two nucleotide states is
debated (50-53). In some studies, GMPCPP-tubulin or GTPγS-tubulin was used instead
of GTP-tubulin; both of these analogs mimic GTP-tubulin properties, but are not
hydrolytically competent resulting in stable microtubules that have subtle structural and
chemical differences from microtubules that incorporate GTP-tubulin. The use of these
8
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synthetic stabilizers adds an additional layer of complexity regarding the overall structure
of the microtubule and its influence on tau-tubulin interactions (50-53). Frequently
invoked together are the diffusion model termed ‘kiss-and-hop’ in which tau samples the
microtubule lattice briefly (47), and tau’s nucleotide preference for GDP-tubulin over
GMPCPP-tubulin (50). Together these two theories lead to an overall enrichment of tau
along the microtubule body, and consequently, a stabilizing effect to the microtubule.
More recently, this view has been critiqued (51). One study with green fluorescently
tagged tau showed that tau preferentially bound to the labile GTP-cap regions of the
microtubule, and depletion of tau led to the loss of microtubule mass in the labile regions
(54). These findings led the researchers to propose tau is not a bone-fide microtubule
stabilizer, particularly in comparison to the stronger MAP6, but instead promotes the
formation of labile/GTP-caps at the ends of microtubules (51). The definitions of tau’s
function do not preclude tau from promoting labile ends but rather are largely in
agreement as they highlight tau’s polymerization capacity. Arguably, the practical
consequence of increasing mass within the labile ends (GTP-cap) is a decrease in the
catastrophe frequency [tau-mediated mechanism of microtubule stabilization (1)]. Thus,
the fundamental underlying mechanism remains unclear. This recent debate emphasizes
the lack of molecular detail of tau-tubulin and tau-microtubule interactions and the ongoing efforts to clarify them.
Within tau, a particular region termed the microtubule-binding region (MTBR)
binds to microtubules. These interactions are predominately electrostatic in nature (5559). It contains four 18 amino acid repeats (R1-R4 in Figure 1.1) with flanking inter8
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repeat regions (IR) (not depicted for simplicity) (55, 60). Both the repeats and the IRs
strongly mediate the tau-tubulin and tau-microtubule interactions (59, 61). While R1-R2
dominate MTBR interactions with lattice-incorporated tubulin (1, 61), with R3 playing a
key role in tau-tubulin interactions (62). See Figure 1.2 for a comparison of the two
aforementioned structural models. Further work demonstrated the importance of R’ and
the C-terminal most half of P2 (amino acids 215-221) in enhancing microtubule affinity
and targeting the MTBR to the microtubule lattice (63-65). Chemical shifts in NMR
spectra of full-length tau have suggested transient association of both the P2 and R’
regions to the both drug-stabilized microtubules and tubulin complexed with capping
proteins derived from stathmins which lock two heterodimers together without
polymerization capacity (65-67). More recently, part of PRR (amino acids 166-246) was
shown to very weakly bind taxol-stabilized microtubules (65). The recent cryo-EM
structure shows tau density from amino acids corresponding to the slightly conserved
binding motif binding tightly in a straight line along the microtubule protofilament ridge
(amino acids 256-267 within R1, specifically sequence VKSKIGSTENLK) (1). However,
the tau construct used in this study was highly synthetic in which the R1 repeat was used
in tandem four times thereby replacing tau’s other 3 repeats. As significant amounts of
both biochemical and complementary structural evidence suggest there are variable
affinities within the MTBR region assembling on the microtubule lattice in a variety of
conformations proposed to be of functional biological importance (58, 63, 67), it is
difficult to directly supplant the traditional picture of tau’s weak and heterogeneous
interactions with this specific linear model.
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The low-resolution of the natural 4R

construct within the cryo-EM images – which was referenced but not modeled – speaks
to this complexity.

Figure 1.1: Tau bound to microtubules and soluble tubulin
From Nogales, Science (2019) and Elbaum-Garfinkle, PNAS (2014)
(A) Cryo-EM model of tau MTBR repeats modeled from R1 and R2 (red) bound to α
(green) and β (blue) tubulin within the microtubule lattice. The C-terminal tails of the
tubulin subunits are indicated by golden star. (B) Tau unbound and the conformational
changes upon binding to soluble tubulin as determined by smFRET.

In better agreement are the regions of tubulin that tau binds, which are well
reflected within the cryo-EM structure. Tau binding sites are located along helices 11 and
12 on both α(-) and β(+) tubulin (68). Tau:tubulin stoichiometry is 1 tau to 2 tubulin
heterodimers (63, 69), and the interdimer interface between α(-) and β(+) of different
heterodimers is favored over the intradimer interface (1). Other motor MAPs including
kinesin-1 share these binding sites (1, 70), leading many to propose a variety of siteocclusion based models for tau’s interactions with other MAPs (12, 71). Additionally, tau
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also binds to synthetic peptides of the intrinsically disordered tails of both α(-) and β(+)
tubulin (68, 72, 73). In fact, these synthetic tails are sufficient to compete tau away from
microtubules (45). Therefore, tau-binding sites are generally located to the C-terminal
half of the tubulin subunits. Tau-tubulin and tau-microtubule interactions are both tau and
tubulin protein concentration dependent (74), as well as salt (58) and pH dependent (75)
reflecting tau’s heterogeneous, electrostatically driven intrinsically disordered character
(76).
Tau isoforms and domains
Broadly, when tau is discussed it is in reference to the 6 major neuronal isoforms
within humans arising from the alternative splicing of the single MAPT transcript (77).
However, other isoforms arising from silenced exons within the human brain exist and
vary across cell type and neuronal tissues (5, 56, 57, 77-85). Similar to the tubulin
isotypes, tau isoforms are spatially and temporally controlled. Furthermore, the tau gene
is both polymorphic containing two major haplotypes (86), and contains an exon-like
intron (intron 9) that produces saithoin – a novel, nested protein within the tau transcript
also associated with the onset of neurodegenerative disorders (87).
Focusing on the best studied human tau isoforms, the largest isoform is found in
the peripheral nervous system (PNS), aptly named ‘big tau’, and contains exons 4A and 6
in addition to exons 2, 3, and 10 (Figure 1.1A) that are alternatively spliced in the human
brain (Figure 1.1B) (5, 88). Few studies have been focused on exons 4A and 6 that
produce additional sequences believed to control microtubule bundling and neurite
extension respectively. Interestingly, exon 6 contains splice sites that result in truncations
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that lack the MTBR altogether (85, 89). The longest tau isoform within the human adult
brain is 2N4R (Figure 1.1B) in which exons 6 and 4A are spliced out leaving exons 2, 3
and 10. Using conventional tau nomenclature: exons 2 and 3 produce inserts 1 and 2 (N1
and N2 respectively) and exon 10 codes for repeat 2 (R2).
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Figure 1.2: Schematic of tau domains and highlighted functions
Adapted from Andreadis Biochimica et Biophysica Acta (2005)
(A) Schematic of ‘big tau’ protein domains with alternatively spliced regions labeled
according to the governing exon. (B) Schematic of the 6 neuronal isoforms with
traditional nomenclature on the right and the percent abundance in the adult human brain
on the left. The fetal isoform 0N3R is indicated. The domains and corresponding residues
that delineate them are marked: N-terminal domain (NTD) with N-terminal inserts (N1,
N2), proline-rich region (PRR) with sub-regions (P1, P2), microtubule binding repeats
(MTBR) with four imperfect repeat sequences (R1-R4) flanked by the pseudo-repeat R'
and the C-terminus.

All of the major 6 isoforms found within the brain are divided into the projection
domain (from the N-terminus to P1) and the binding domain (P2 to the C-terminus) with
some studies further splitting tau into a third ‘hinge’ region primarily composed of the
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proline rich region (PRR) and the C-terminal most region of the NTD (63, 88, 90). Based
loosely on sequence charge characteristics and homology, tau is divided into 4 major
regions: the highly negatively charged N-terminal domain (NTD), the proline rich region
(PRR), the microtubule binding region (MTBR), and the C-terminal tail (63). The NTD
along with P1 of the PRR regulates the spacing between microtubules through
electrostatic screening between the two oppositely charged regions (11, 63, 74, 91, 92).
The P2 region of the PRR is critical for tau-mediated tubulin polymerization and
microtubule binding (67, 93-95), although the underlying mechanism is unclear (66, 93,
96). Additionally, within the PRR region are a large number of kinase and phosphatase
sites thereby associating the PRR as a primary site for cellular partner recruitment and tau
regulation (3). The MTBR contains 4 pseudo repeats spaced by interlinking regions
called inter-repeats (IRs) each of which contain a weak binding site for tubulin (60, 61,
93). Following the MTBR is the C-terminus, which contains a 5th pseudo repeat termed
R’ that has been shown to bind to tubulin and enhance formation of tau-tubulin ‘fuzzy’
complexes (58). Both the NTD and C-terminal most ends are also considered regulatory
features that recruit other cellular partners.
Focusing on the human neuronal isoforms, the combinatorial presence of 0, 1 or 2
inserts and 3 or 4 repeats gives rise to the 6 isoforms termed: 2N4R, 2N3R 1N4R, 1N3R
0N4R, and 0N3R. These isoforms are developmentally regulated with varying
distributions of isoforms across developmental stage, cell type and cellular location (5,
88). Most notably, 0N3R is the sole isoform in fetal brain tissue with the additional
inserts and repeats only appearing later in life (56, 83). Interestingly however, the
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emergence of additional tau isoforms is not correlated with temporal development of the
neuronal tissue itself – ‘older’ tau isoform levels rise together across regions of the brain
that mature at different rates such as the neocortex and the cerebellum in fetal rats (97).
The MTBR isoforms (3R and 4R) have appreciable differences in both microtubule
binding and polymerization capacity (61, 63). By comparison, the differences between
NTD isoforms in microtubule binding, polymerization, and bundling are subtle (11, 63,
74, 91, 92), and consequently, it has been proposed the precise function of the NTD
isoforms has not yet been discovered (3). Additional complexity comes from various
disease states, in which aberrant tau isoform ratios drift from the healthy state. The best
characterized of these is exon 10. The ratio of the 3R to 4R isoforms is tightly regulated
at 50:50, and divergence from this ratio is a biomarker for Alzheimer’s disease although
details and the underlying functional mechanism of these two isoforms remain unclear
(98). Within the projection domain, early stages of neuronal apoptosis result in Nterminal truncations (99-101), and excessive levels of 2N isoforms are associated with
gliopathy and spinal cord degeneration (102). Finally, tau transcription is also overall
increased in those with Down’s syndrome (103). Altogether, these deviances from
‘normal’ tau transcriptional levels and their tight developmental and cell-dependent
regulation, have led researchers to propose it is the ratio of tau isoforms that dictate
healthy tau function rather than the precise isoform present (88).
Intrinsically disordered proteins
Tau belongs to a class of proteins that lack stable secondary structure and tertiary
structure termed intrinsically disordered proteins (IDP). IDPs and smaller intrinsically
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disordered regions (IDR) compose approximately a third of the proteome (104). On the
extreme end of intrinsic disorder, some IDPs and IDRs randomly sample space only
influenced by the peptide backbone itself and are unconstrained by inter-residue
interactions (hydrogen bonds, pi-pi stacking, electrostatic interactions, etc) associated
with higher order structures within structured proteins (105, 106). Within this thesis, I use
the Gaussian polymer chain model that describes each amino acid as a randomly oriented
monomer as a part of a polymeric chain that is bonded freely to the next monomeric unit.
This Gaussian polymer chain samples space as a statistical distribution of states
representing a variety of conformations within the polypeptide restrained only by the
peptide bond length. (105, 106) Collectively the entire distribution of conformational
states is termed a conformational ensemble. When the peptide bond length is the only
restraining feature of this conformational ensemble, it is termed a random coil (106). A
simplified cartoon version of a random coil is drawn in Figure 1.3A. However, not all
conformational ensembles are random coils. Although conformational ensembles more
broadly sample conformational space than the canonical well-folded domains α-helices
and β-sheets; conformational ensembles can have conserved characteristics. Unlike
structured proteins that have conserved and predictable motifs secondary and tertiary
motifs, the driving characteristics of IDPs are primarily based on the primary amino acid
sequences (107-110). Differing sequence characteristics – most importantly the fraction
and distribution of positive and negative charges – determine the degree of compaction or
expansion and segregate IDPs into different sub-classes (108, 111). More recently, the
linear patterning of amino residues proved to be a strong predictor of IDP character
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besides just their net composition within the sequence, and the suite of correctional
theoretical considerations (pi-pi stacking from aromatics, steric restrictions from prolines,
increased hydrophobic character, etc.) in IDP character prediction is rapidly expanding
(111). These biophysical parameters thereby limit the random coil’s distribution of states
within the conformational ensemble resulting in a less extended conformational ensemble
that still broadly samples space but with additional biophysical constraints in comparison
to the random coil (Figure 1.3B) (111). Additionally, transient secondary structures may
form within the IDP itself (Figure 1.3C). This transition may driven by post-translational
modification (112) or binding to a ligand (113) (discussed in subsequent paragraphs).
On top of IDP structural heterogeneity are inter-protein interactions. The disorder
of IDPs or IDRs has known physiological roles of biological consequence including
transcriptional regulation, cell signaling, and chaperone activity (112, 114, 115). The
most frequently encountered examples are as ‘spacers’ between structured domains that
remain unresolved in atomically resolved x-ray crystallography structures. Another
related form of this function is a molecular cushion in which an IDP functions to space or
‘cushion’ interacting cellular partners such as tau’s N-terminal domain (NTD) and its role
in microtubule bundling (63, 74, 91, 92). Beyond regulating space and dynamics, many
IDPs contain binding sequences. These can collapse in a disorder-to-order transition upon
binding (113).
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Figure 1.3: Intriniscally disordered proteins and their ensembles
(A) A noodle diagram of a random coil protein. Alternating regions of red and blue are
for added clarity. Black arrows indicate a single peptide bond and its orientation. (B) A
noodle diagram of a conformational ensemble with the same length alternating red and
blue regions from (A) to demonstrate relative restricted movement of the protein in
comparison to a true random coil as drawn in (A). This may be due to several biophysical
factors. For example, a hydrophobic pocket (shaded gray) may cause collapse in a
particular region of the ensemble and favor a particular global architecture devoid of
canonical secondary structure and still very heterogeneous and dynamic. (C) The
formation of an alpha helix (red cylinder) in equilibrium with a conformational ensemble.
(D) The binding of a ligand to a multivalent IDP. The binding of a ligand may not result
in a conformational change within the IDP region it binds but will still bind specifically.
This is termed a ‘fuzzy’ complex. Different binding valences with similar conformational
ensembles can be grouped together into a ‘subclass’ (boxed). The binding of the ligand
may cause conformational changes within the IDP. Each individual conformation with a
specific bound ligand is a microstate. Altogether, the different binding valences and
conformations grouped together are termed a global ensemble. It is important to
remember each microstate and the unbound state are all in equilibrium with each other.

However, an ordered binding state is not a pre-requisite, and in many cases the disordered
binding region and its transient interactions are favorable and biologically relevant. One
common and widespread example is of a PTM to a disordered region resulting in
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transient binding to a cellular partner during signal transduction (112). In this case, the
binding interactions are stochastic, and the IDP contains a significant amount of
structural heterogeneity on the surface of its bound partner. When these disordered
interactions are specific but the structural disorder is still maintained, the heterogeneous
structural conformations between the two bound proteins are collectively termed a
‘fuzzy’ complex (116) (Figure 1.3D).
The fundamental biophysical parameters of bond length, primary amino acid
sequence, and electrostatic or hydrophobic interactions are the same within both classes
of structured and intrinsically disordered proteins but the relative number and the
corresponding net strength of each factor in governing net interresidue interactions varies
between the two classes of proteins. For many IDPs and IDRs, a ‘structure’-function
description of one specific state is misleading in that these classes of proteins sample
large conformational spaces. In some cases, this conformational ensemble persists in the
bound state and may be multivalent. Prior work modeling multivalency of synthetic SH3
linked domains demonstrated binding configurations, specifically in transient
nonequilibrium states, were influenced not only by the valency of the synthetic peptide
but also by linker length and linker rigidity (117). Importantly, both the valency and IDR
character of the linkers influenced early-stage binding dynamics. In this study, the
authors introduced the idea of microstates in which one microstate represents a specific
combination of the conformational state with one or more specifically occupied binding
sites. Here, stoichiometry and occupancy are different – occupancy of sites 1 and 2 within
in a trivalent system is different from occupancy of sites 2 and 3 resulting in two distinct
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microstates (117). For both microstates, the stoichiometry is the same. In this model, all
the binding affinities were assumed to be equal. To reiterate, a microstate is one specific
conformation and occupancy of an IDP or IDR bound to its partner with the associated
thermodynamic factors (Figure 1.3D). These microstates and the equilibrium between
them are represented as a network that can be then modeled and predicted using ordinary
differential equations (Figure 1.3D). Specific subsets of microstates were collected
together into subclasses based on conserved conformational characteristics (117). A
subclass is a set of microstates that have subtle differences in their precise conformation
that results in energetic differences despite identical stoichiometry to the bound partner.
Depending on the steric constraints of the given conformations, certain subclasses were
enriched in comparison to other constrained subclasses. The dynamics between
subclasses and the individual microstates represents a dynamic network (117). Inherent in
their model is what I will term a global ensemble (Figure 1.3D).
A global ensemble is the probabilistic distribution of microstates – which may or
may not be uniformly distributed into one subclass or modally distributed into multiple
subclasses – that are in equilibrium with each other. Underlying all equilibrium are
fundamental physical parameters of the energetic landscape. Therefore, a global
ensemble can be influenced by perturbations such as binding of a novel ligand or
environmental factors such as ionic activity. The altered energetic landscape would result
in a ‘rerouting’ of populated microstates and larger subclasses. It is possible certain
subclasses may have different biological functions. Therefore, previously unpopulated or
underpopulated subclasses with a certain biological function would become populated
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and a new emergent biological function would characterize the global ensemble. The
same fundamental states would still be present within the system but a seemingly new
emergent property would be evidenced.
Once again, tau serves as an example. Tau is an IDP with a conformational
ensemble that deviates from a random coil and binds multiple tubulin dimers (62, 118,
119). Upon binding to tubulin, there are conformational changes throughout the protein
(62, 118, 119). Previously, our lab demonstrated that the MTBR maintains an overall
compact structure when bound to tubulin in solution, but that each individual repeat
expands upon binding (119). It was hypothesized that the flanking repeats compacted in
order to accommodate changes within the MTBR upon binding to a tubulin subunit with
differences evidenced between the MTBR isoforms (119). Additionally, shifts in the ETeff
of two different FRET pairs (one spanning the N-terminus to the middle of the protein,
and another spanning sites within the MTBR) occurred at different concentrations of
tubulin, indicating a two-state conformational change within tau upon binding to tubulin
(119). Additional work demonstrated that the degree of ‘fuzzy’-complex formation and
the number of weak binding sites within the microtubule binding region (MTBR) and
flanking pseudo-repeat R’ positively correlate with microtubule polymerization (58).
Whether or not the precise occupancy at every potential binding site is influenced by or
dictates the conformational ensemble is unknown. It is therefore important to consider
both the occupancy and conformational ensemble when studying tau-tubulin interactions.
One way to represent the convoluted conformation and occupancy of tau-tubulin
interactions is with the network global ensemble interpretation (Figure 1.4). For example,
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while a tubulin dimer may be bound in the R1 repeat, the NTD may be expanded or
compressed resulting into two separate microstates (Figure 1.4B) belonging to two
separate subclasses (Figure 1.4C). If the two separate subclasses would each have five
different microstates (considering five possible tubulin binding sites in the MTBR-R’) all
of which are in equilibrium with each other (Figure 1.4C, bottom graphic). In practice, it
serves as a theoretical, pictorial backdrop to avoid common incorrect implications that
arise when discussing IDPs – that a single microstate is present with a specific valency
and occupancy. Bluntly, the network picture of microstates and subclasses with the global
ensemble serves only as a theoretical basis to emphasize the balance and heterogeneity of
both the IDP conformation as well as the precise occupancy and stoichiometry. This is
particularly advantageous when a particular microstate or subclass leads to a committed
biological response – such as an aggregation-prone state – and therefore influence the
overall global ensemble in a unique way to other subclasses or microstates regardless of
the most populated microstate or subclass within the system. From an experimental
standpoint (further discussed in section “Common experimental techniques”),
distinguishing individually each microstate within globular proteins is challenging, if not
impossible, let alone within the more conformationally heterogeneous IDPs. While this
network representation has practical modeling and theoretical advantages, it is important
to remember that this representation is more granular than conformational ensembles
within IDPs whose ‘structures’ remain best captured by the noodle diagrams in Figure
1.3. Understanding the underlying biophysics of these tau-tubulin ensembles is directly
applicable to understanding their biological function. For example, the propensity for the
unbound versus bound state in tau-tubulin ensembles was altered by two tau disease point
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mutants associated with Alzheimer’s disease, P301L and P322L. This study of point
mutations impacting tau-tubulin assembly demonstrated that the equilibrium of states (or
the global ensemble) within tau-tubulin assemblies can be altered by small changes to the
energetic landscape (62).
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Figure 1.4: Network modeling as applied to tau-tubulin interactions
(A) Cartoon of tau-tubulin binding. The MTBR-R' (red) binds to tubulin through
distributed, weak interactions. The NTD expands upon tubulin binding. The PRR and Cterminus are colored orange and black respectively. The incoming tubulin dimers are
bound at particular sites as indicated by a red asterisks (*). B) Example microstates in the
first and second tubulin binding event to regions MTBR-R’ with hypothetical expansion
of the NTD distinguishing subclasses “E” and “C”. C) Possible microstates in the first
tubulin-binding event separated into two subclasses “E1” and “C1”. Two hypothetical
subclasses ‘C1’ and ‘E1’ represent a closed and open formation for the NTD,
respectively. These two subclasses are in equilibrium with each other as is each
microstate within each subclass.
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Recently, IDRs and IDPs have come to the forefront of attention due to the
discovery of liquid-liquid phase separation (LLPS) within cells (120). Phase separation,
or the formation of biomolecular condensates, is the selective sequestration of
macromolecular biomolecules such as RNA or protein into a liquid-like droplet (121).
They are remarkably sensitive to environmental conditions, and can be triggered by both
small molecules and macromolecules such as RNA (120, 122). These separate phases are
proposed to drive the formation of membraneless bodies such as the nucleolus (123), and
have several far-reaching implications for developmental biology, enzymology, cell
signaling and mechanics. Indeed, the phase separation of tau nucleating bundled
microtubules has recently been proposed as mechanism for microtubule initiation in
axons (124). Comparing LLPS states to dissolved (un-separated) IDP microstates and
global ensembles presents yet another concentration-driven layer to IDPs interactions. It
also emphasizes the sensitivity of these proteins under a variety of experimental
conditions.
Common experimental techniques
Experimentally probing the structural heterogeneity of IDP interactions is
uniquely challenging. IDPs and IDRs are conformational ensembles that represent a large
distribution of conformations. Consequently, bulk structural experimental techniques that
include averaging steps probe primarily either the average structure of the entire
ensemble or the most frequently populated structure depending on the experimental
design. For example, x-ray crystallography relies heavily on homogeneous and periodic
structural characteristics to capture scattered electron densities (125). IDPs and IDR
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sections generally do not have measurable electron densities, and are therefore
unresolved in x-ray crystallography structures. Consequently IDP and IDRs are not easily
probed using this approach. Nuclear magnetic resonance (NMR), circular dichroism
(CD), and cyro-EM are better suited for heterogeneous structural information (76)
although all of these techniques rely on averaging within the experimental design.
Both NMR and CD use signal-averaging techniques. NMR perturbs the
artificially aligned magnetic moments of individual nuclei within a molecule, and then
measures the resulting electromagnetic frequency of their relaxation back to the aligned
external magnetic moment (126). Therefore theoretically, each nucleus within the protein
is measured individually. However, due to detection sensitivity, only sufficiently
populated conformations are detected. Within the NMR field, extending the detection
power of smaller populations is enhanced by literally using a bigger and stronger magnet,
which increases the number of aligned particles prior to perturbation as well as increases
signal strength and sensitivity. Additionally, all the detected frequencies are collected
together. A particular nucleus that is experiencing a uniform distribution of different
nuclear fields (chemical environments) will be measured as an averaged broad frequency.
Thus, while NMR successfully collects heterogeneous and dynamic information from
protein conformational ensembles, it is dependent on sufficient levels of a given
conformation with distinctive frequencies to successfully distinguish different
conformations. NMR has been frequently and successfully employed to probe tau’s
solution structure and when bound to microtubules or stathmin-stabilized tubulin
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oligomers (65, 67, 127). In these studies, NMR has shown transient secondary structures
within two of tau’s regions, the MTBR and proline rich region (PRR) (67).
Similarly, CD averages a given signal within a bulk sample. In CD however, the
observable is the polarity of absorbance of near-UV light (typically 260 nm to 180 nm)
(128). This technique probes the amide-backbone of secondary structures such α-helices
and β-sheets. The entire signal from all the conformations and populations within the
sample are collected together at each wavelength representing a sum of the ellipticity of
all the conformations weighted by relative populations and characteristic intensities. In
comparison to NMR, CD is far less sensitive as each peptide bond absorbs within the
same wavelength range and the all the measured polarities at each wavelength are
measured and averaged together (128). CD is essentially a bulk measurement
representative of the average of the entire conformational states. Thus, while NMR can
experimentally resolve a bi-modal set of conformations by measuring two distinct peaks
from a continuous distribution of conformations, CD cannot and the measured signal
represents an average of the entire sample. However, additional computational and
theoretical modeling of CD data or supplemental experiments can de-convolve separate
populations within the sample.
Cyro-EM does capture individual conformations by taking thousands of EM
images of immobilized particles orientated randomly on the detection grid. (129)
However, in comparison to NMR and x-ray crystallography, the atomic resolution of
these images is significantly lower (typically ~0.2 nm) (129). To overcome this resolution
limit, thousands of EM images are classified and then summed together to form a more
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accurate 3D image density. This 3D image density can then be modeled similar to an xray crystallography structure (129). In this experimental technique, the building of the
classes prior to 3D structure determination is an averaging technique in which images are
summed together according to their relative populations (129). Recently, cyro-EM was
successfully employed to deliver near atomic-resolution of synthetic tau constructs bound
to stabilized microtubules (Figure 1.2) (1). Unfortunately, many key tau regions
surrounding tau-microtubule interactions are missing from this most recent structural
advancement, such as the PRR and R’, highlighting the need for continued focus on the
heterogeneous, largely unstructured, and dynamic tau-microtubule and tau-tubulin
interactions.
Single-molecule techniques have a greater discriminatory power when examining
individual conformational states within conformational ensembles in comparison to other
techniques with averaging steps. Single molecule Förster resonance energy transfer
spectroscopy (smFRET) uses the distance-dependent energy transfer between two dyes to
measure the distance between two points (130-132). SmFRET techniques are diverse
(133); for brevity I will discuss the technique used in this thesis – solution and intensity
based intramolecular FRET. In this case, picomolar concentrations of a doubly labeled
protein diffuse through a focused laser confocal volume (approximately a femtoliter in
volume) (Figure 1.4A) (130). The probability that two molecules occupy the confocal
volume is low, and therefore individual molecules are measured. The laser excites the
donor dye that either fluoresces or transfers energy nonradiatively to the acceptor dye
which in turn also fluoresces (Figure 1.5A) (131). The laser is focused and the incident
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light on the sample is great; consequently, the sample is ‘flooded’ with excitation light.
Furthermore, both the direct emission of the donor and the energy transfer between the
dyes are fast (on the ns timescale). The fast timescale of FRET events and ample
excitation light allow for many photophysical events to occur within the timescale of the
experiment, which is limited by the ~ 1ms diffusion of most proteins. Therefore, photons
from both the donor and acceptor fluorophores are measured although they do not occur
simultaneously (Figure 1.5A). The efficiency of the energy transfer is distant dependent
and can be calculated using the using the Förster resonance energy transfer equation (Eq.
4 in Appendix I.iv). As the dyes come closer together, the probability of energy transfer
increases and greater efficiencies are measured (Figure 1.5B, top and second panel).
However, if the distance between the dyes is too great, the probability of energy transfer
drops to zero (Figure 1.5B, third panel).
When a sufficiently large number of events are collected (typically in the tens of
thousands), the individually calculated energy transfer efficiencies are plotted as a
histogram. For IDPs, these histograms are frequently fit with one of a number of polymer
models in order to convert the energy transfer efficiency distribution to a distance
distribution (Figure 1.5B) (130, 131, 133). This thesis uses the Gaussian coil model
(discussed in “intrinsically disordered proteins”). The range of distances that can be
accurately determined is dependent primarily on the chosen dye pair. Within this thesis, I
use FRET dye pair Alexa-Fluor 488 and Alexa-Fluor 594 allowing me to probe distances
between 30 – 100 Å (134). SmFRET with the same dye pair has been previously used to
characterize both a fragment of tau’s unbound and bound structure showing in which the
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N and C termini become more distant upon binding to tubulin with variable compaction
within each MTBR repeat (118, 119). With smFRET, individual distances are not
averaged or detected together in bulk, although frequently the average root mean squared
distance (RMSexp) from the fitted histogram is reported along with the histogram
distribution of energy efficiencies or converted distances (Figure 1.5B) (130). Although
not frequently quantified, the breadth of the measured histogram may reflect the
dynamics of conformational sampling by the protein – a broad peak may reflect slow
(relative to the timescale of the measurement) sampling of distances between the two
dyes (Figure 1.5B) (135, 136). For example, the relatively slow sampling of
conformational states between two fluorophores would result in a broad histogram
(Figure 1.5B, top panel) while more rigid and constrained regions such secondary
structures may have a narrow histogram (Figure 1.5B, fourth panel) (135, 136). However,
interpreting the breadth of peaks is convoluted; one important possibility is that different
populations within the sample that are not distinguishable or stably populated (135, 136).
For example, consider a transiently folded helix within an otherwise folded protein. Only
if the folded and unfolded distances are sufficiently different and also stably populated,
the two separate populations can be detected and quantified (Figure 1.5B, bottom panel)
(136). Very broad peaks, however, make unique populations difficult to separate from
heterogeneous or transient ones (132, 135, 136). Within smFRET, only the distances
between each dye pair are measured, and residue-specific information is missing (Figure
1.5B). Therefore, 3D models are experimentally difficult to build with smFRET data
alone. FRET constrained molecular dynamic simulations provide additional structural
resolution (119).
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The advantage of a single-molecule structural technique is in cases when there is
a small population of a unique conformational population not characteristic of the bulk or
average protein. Continuing with our transiently folded helix example, consider the case
in which only 5% of the helix is unfolded and the transition between these two states is
slow (on the ms timescale) (Figure 1.5C). Using smFRET and a variety of appropriately
placed dye positions, the unfolded population would be detected although a full model of
the structural protein would still be missing (Figure 1.5D). If the same structure was
probed using NMR, the individual nuclei would give rise to a variety of frequencies,
some clearly distinguishable and others more broad, reflecting their molecular movement
and yielding an atomic model with a number of potential conformations within the IDR
regions (Figure 1.5E). However, unless the population of the unfolded helix was
sufficient, it would go undetected as a separate state within the protein global ensemble
(Figure 1.5E) using NMR. If the same protein were measured using cryo-EM, the
measurable densities would correspond to primarily to folded regions and a 3D model
could be threaded with known homologous structures (Figure 1.5E). Here, although the
unfolded population would be captured on the EM grid, it is unlikely the unfolded region
would be preserved through the 2D class analysis due to both poor resolution from its
IDP nature and its overall low population within the sample. For both cryo-EM and
NMR, whether or not the small unfolded region is detected is dependent on the both the
strength of the instrument’s detection and the percentage of the population each
conformation comprises. This problem is amplified in IDP systems that contain a very
large number of conformations and consequently the proportion of each individual
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conformation is lower. Using smFRET overcomes the need for sufficient levels within
each population to be detectable as a single-molecule technique (132, 133).
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Figure 1.5: Structural experimental techniques
(A) Doubly-labeled protein diffusing through a focused laser beam. The confocal volume
indicated by a dashed black circle. When the protein diffuses through the confocal
volume, the donor dye is excited which in turn excites the acceptor dye. Both
fluorescence intensities of the donor and acceptor are recorded together. (B) A protein
model with two dyes that are a FRET pair. Orange arrows represent a beta sheet, the red
cylinder an alpha helix, and the black lines represent IDR regions. The energy transfer
between the two dyes is distance dependent and can be calculated to give the energy
transfer efficiencies (ETeff) between the dyes (represented by dashed blue line). Due to
molecular movement (indicated by the solid blue double arrow), the distance between
these two dye pairs fluctuates. If sufficient FRET events are recorded, a histogram of the
ETeff emerges, and can be fit with models to give the corresponding distances (first
panel). When the dyes are close together, the histogram shifts to higher ETeff (second
panel), but if the dyes too are far apart there will be no energy transfer, and the recorded
fluorescence is only that of the donor (third panel). This lower peak centered on zero, in
which no FRET is occurring, is termed the ‘zero-peak’. The width of the histogram may
also reflect the degree of molecular movement between the two dyes resulting in
narrower peaks for relatively immobile regions (fourth panel). When two different
conformations exist between the dyes, then two peaks will be detected. This is assuming
the two conformations have sufficiently different distances to be distinguishable (bottom
panel). (C) Hypothetical example of a folded protein with an unstable helix that
comprises 5% of the total protein population with molecular dynamics on the ms
timescale. (D) Probing the system in (C) using smFRET. Using a few dyes positions,
distances (black dashed lines) can be extracted but not residue specific information.
Without additional experimental probes and molecular molding, the protein tertiary and
secondary structure remains unknown (represented by gray protein cartoon). However,
assuming appropriately placed dyes, the unstable helix would be detected (red dashed
line). (E) Probing the system in (C) using NMR. Each labeled nuclei (here nitrogen) can
be detected with a characteristic chemical shift (δ, ppm). Depending on the molecular
movement and its timescale, the chemical shifts may be sharp and intense (light blue) or
broadened (dark blue). With proper chemical labeling and pulse sequences, an entire
molecular model of the protein can be built. The multiple lines for the IDRs represent the
possible ensembles based on the detected broad peaks. However, small populations are
generally below the detection limit of most NMR machines, and the unfolded helix would
not be detected but hidden within the noise. (F) Probing the system in (C) using cryoEM. Each individual conformation is detected on the EM grid. However, the 3D class
average generally will not contain the IDRs or the disordered helix. Additional molecular
detail comes from modeling homologous proteins into the 3D class average.
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Finally, fluorescence correlation spectroscopy (FCS) can be used to detect the size
of a fluorescently labeled species as it diffuses through a focused laser, again about a
femtoliter in volume (130, 137). Similar to smFRET, the fluorescence intensity of a
fluorescently tagged molecule is measured. In FCS, the fluctuations of that fluorescence
intensity are autocorrelated and the resulting autocorrelation curve can be fit using the
appropriate diffusion model (Figure 1.6A) (130, 137). Qualitatively, larger complexes
shift the midpoint of the autocorrelation curve (G(τ)) to longer times and consequently
have larger diffusion times. Additionally, the magnitude of the autocorrelation curve at
time 0 is inversely correlated with the number of molecules, this corresponds to an
increase in the number of molecules measured within the confocal volume as the
amplitude decreases (Figure 1.6A). Quantitatively, biophysical parameters such as the
number of molecules within the confocal volume, the average brightness or counts per
molecule (CPM), and diffusion time can then be extracted (138). If proper standards are
measured on a calibrated system, diffusion times can be converted to the molecule’s
radius if it is assumed a sphere (most commonly the radius of interest is the
hydrodynamic radius).
As FCS is sensitive to the molecule’s size, it can be used to determine ligand
binding. Accurately fitting and quantifying changes in diffusion times between the
unbound and bound species within the same sample requires a 8-fold increase in the mass
ratio of the measured globular protein species due to mathematical and experimental
restraints (a two-state diffusion model) (138). However, small changes in diffusion times
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for the entire sample are easily measurable and can be considered in terms of their trends
(a single-state diffusion model in which the average diffusion time of the entire sample is
reported) (Figure 1.6C). These diffusion time averages are typically of several molecules
at a time (in this thesis, ~10 to 20 molecules). This makes FCS an extremely useful
technique for selectively measuring the diffusion times of protein-ligand complexes in a
semi-single-molecule manner. As ligand is titrated into a solution of labeled protein, the
diffusion time shifts to longer diffusion times (Figure 1.6B). Plotting the diffusion time
(τD) against the ligand concentration produces a binding curve (Figure 1.6B). However,
as the size of the protein complex is being experimentally measured, conformational
changes and ligand binding are convoluted and extracting binding parameters (such as the
apparent binding affinity, KD) may require additional or supplemental experimental
information. Furthermore, the error in the number of molecules detected can vary
between 20-30% due to photophysical damage to the fluorophore (138). Despite the low
resolution of conformational information, FCS informs on the heterogeneity of
multivalent ensembles as it detects changes is molecular size in a semi-single-molecule
manner (58, 62, 130). As conformation and occupancy are convoluted, distinguishing
separate microstates may not be possible. Instead, a spread of diffusion times and
brightness within the ensemble are measured and are qualitatively distinguishable from
homogeneously uniform samples (Figure 1.6C) (58). The spread of diffusion times
indicates multiple different species within the sample that may indicate a larger network
of microstates than within a homogeneous sample. A homogenous sample may still
contain an equal number of microstates and subclasses as its heterogeneous counterpart,
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but they would all be indistinguishable using FCS. Complementary structural techniques
such as NMR or smFRET may inform on the conformational ensemble and the number of
subclasses while calorimetry techniques to distinguish differential binding events may
distinguish different occupancies.

D

G( )

intensity

increasing number
of molecules

time

% intensity

A

increasing
diffusion time ( D)

particle size

Sedimentation
co-efficient

gravity

time

[ligand]

F

anisotropy

increasing
[ligand]

diffusion

D

G( )

B

continuous
distribution

E

time

increasing
concentration

t t+

y

C

x

[ligand]
G( )

G( )

G( )

G

time

unbound

homogeneous

time

association (kon)

D

binding

time

time

heterogeneous

Legend on page 33.

8

32

dissociation (koff)

Figure 1.6: FCS and common complementary experimental techniques
(A) Singly-labeled protein diffusing through a focused laser beam. The confocal volume
indicated by a dashed black circle. When the protein diffuses through the confocal
volume, the dye is excited and the fluorescence intensities are recorded. The fluctuations
in intensity are autocorrelated in time, resulting in an autocorrelation curve (G(τ)). The
midpoint of the autocorrelation curve increases in time with increasing diffusion time
while the amplitude at t=0 decreases with increasing number of molecules detected
within the confocal volume. (B) As FCS is a measurement of size, it can be used to
measure ligand binding. As unlabeled ligand is added to a labeled protein sample the
overall diffusion time increases. The increasing diffusion times can be plotted as a
function of ligand concentration to measure binding. (C) FCS is a semi-single molecule
technique. Each measurement can be fit with a diffusion time and the corresponding
spread reflects the degree of heterogeneity within the sample. Affinity, conformation, and
stoichiometry are convoluted together as the size of the complex is measured as indicated
by gray circle around model protein. (D) DLS measures the scattered light from an
incident laser beam on a diffusing molecule. As this method does not use a fluorophore,
the relative intensities of all the particles are reported. (E) AUC uses gravity to establish a
concentration gradient as well as further distinguish heavier particles between similarly
sized ones. This technique therefore allows for a continuous distribution of species to be
determined and can potentially more accurately determine stoichiometry. (F)
Fluorescence anisotropy is another method commonly used to determine binding. It uses
polarized light and the resulting change in polarization from the fluorescence of a dye to
calculate anisotropy. The anisotropy can then be plotted against ligand concentration. (G)
SPR uses ligand immobilized on a gold film. The angle at which the light is resonant and
reflected from the film is sensitive to the binding of incoming protein. This two-phase
experiment in which incoming protein is flowed into the chamber and then subsequently
buffer to remove the protein provides information on stoichiometry and kinetic
information.

Similar to FCS, dynamic light scattering (DLS) and analytical ultracentrifugation
(AUC) also measure the size of particles and provide the relative distributions of sized
particles within the sample. For DLS no fluorescent labels are needed as it uses a
collimated laser beam (a perfectly straight laser beam that theoretically does not diffuse
or come to a focused point) (139). The light from the laser is scattered by particles and
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observed; the relative intensities within the sample and particle size of the various species
are calculated (Figure 1.6D) (139). In this case, there are additional photophysical
characteristics that need to be considered. Examples include the surface of the scattering
molecule and the angular dependence of the scattered light (termed anisotropy discussed
at length later). These factors result in additional convoluting factors when analyzing
DLS data (139). Although the fundamental photophysics are different, many theoretical
and mathematical principles of FCS are derived from DLS and the two techniques face
similar challenges. An advantage of DLS is that all species within the sample are
quantified – not just the labeled protein of interest. However, this includes aggregates and
dust. The reporting fluorescent label used in FCS allows for only the protein of interest
and its ligand bound species to be analyzed.
Another fluorescent-independent diffusion-based technique is AUC. However, in
AUC an additional force – gravity – is used to further discriminate particles based on
weight and in part size (arises from drag) as the particle sediments (Figure 1.6E) (140).
Due to the added force, a gradient across the sample is established, and therefore
concentration of the species can be readily determined (140). This results in a continuous
distribution of species characterized by their sedimentation co-efficient which is a
determined by size and molecular weight (Figure 1.6E) (140). Fluorescent dyes can be
added to further discriminate between species, and the measured fluorescence intensity
can also be used to calculate concentration (140). One power of AUC is that
stoichiometry can be determined accurately. The drawback is the length of time to
acquire AUC data may be prohibitive for some systems. Interestingly, the sedimentation
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co-efficient for tubulin changes throughout an AUC experiment (141). Whether this is
due to instability of the protein or the concentration gradient is unknown. However, AUC
with fluorescently labeled tau has been successfully used to characterize the
stoichiometry of tau bound to soluble tubulin (142). However, AUC is a bulk
measurement and single-molecule statistics are not quantified. This leaves an individual
microstate’s detection dependent on its relative population within the sample.
As previously mentioned, buried within DLS data analysis are anisotropy values
which can inform on the overall shape of the molecule. Anisotropy is the angular and
directional dependence of a physical characteristic. However, many techniques to
measure the anisotropy of physical properties exist and a thorough discussion of them all
is beyond the scope of this thesis. Here, I will highlight one method in particular –
fluorescent polarization (typically referred to as simply ‘anisotropy’) (Figure 1.6F) (143).
In this method, polarized light is absorbed by fluorescent molecule which then emits the
light along several axises as it tumbles through the solution (Figure 1.6F). Depending
primarily on the fluorophore’s immobility and the diffusion of the labeled species, the
emitted light may also be polarized along a separate angle from which it was absorbed
(143). The ratio of fluorescent intensities along these axises are calculated. As ligand is
added and the size of the molecule increases there is a corresponding change in
anisotropy (Figure 1.6F) (143). Once again, this is a bulk technique, and it is difficult to
capture statistics that look at the heterogeneity of microstates within the sample.
Unique to the above techniques, surface plasmon resonance (SPR) can provide
kinetic parameters, concentrations, and affinities of protein-ligand interactions without
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additional supplemental experimentation (Figure 1.6G) (144). Briefly, ligand molecules
are immobilized on an electrically conductive surface whose index of refraction and
resonance with the incoming polarized light changes upon binding of the analyte protein.
If the degree of binding is plotted with time, the association and dissociation phases
contain kon and koff, respectively (Figure 1.6G) (144). Although an exceedingly powerful
technique, SPR is both difficult and expensive as the conductive layer is traditionally
made of gold and is exceptionally susceptible to experimental noise (144). Furthermore,
the technique requires the immobilization of ligand on the surface that may or may not
interfere with protein-protein interactions. SPR has been successfully used to study tau
peptides interactions with proteins found in neurodegenerative diseases (145), but to the
best of my knowledge, not tau-tubulin interactions. Again, SPR is not a single-molecule
technique but a bulk film measurement. The potential resolution of different microstates
comes from advanced theoretical and mathematical modeling from this information-rich
technique (117). However, this has yet to be developed across a variety of systems and
remains a primarily theoretical consideration for all the above techniques including SPR.
Finally, the above experimental techniques have varying restrictions on protein
concentration, buffer conditions, and sample preparation. NMR, CD, cryo-EM, DLS, and
AUC generally require milimolar concentrations or protein (126, 128, 129, 139, 140).
While NMR, DLS, and AUC are amenable to varying buffer conditions (126, 139, 140),
CD and cyro-EM are comparatively limited due to interference from various salts (128,
129). Furthermore, cyro-EM requires immobilization of the sample on the EM grid, and
sample optimization is required to ensure protein-protein interactions are not altered
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(129). While smFRET and FCS are not broadly restricted by buffer conditions, assuming
they are not fluorescent, these techniques are limited to the picomolar and nanomolar
protein concentration range (130). As previously discussed in “Intrinsically disordered
proteins”, IDPs and IDRs are very environmentally sensitive and have concentrationdependent behaviors. Many structural and biochemical studies focusing on taumicrotubule and tau-tubulin interactions frequently used buffer BRB80 (63, 65, 67, 127).
BRB80 contains the nonphysiological buffer component piperazine-N,N’-bis(2ethanesulfonic acid) (PIPES) and was developed for purification of soluble tubulin from
MAPs (146). Here I use a low ionic phosphate buffer that is more physiologically
relevant; details in the screening of tau:tubulin interactions are discussed in Chapter 3 and
Appendix I.
As I am interested in the broad heterogeneity of the system both in terms of
conformation and occupancy rather than elucidating a specific representative structure (a
specific microstate), I have chosen FCS and smFRET as my experimental techniques.
Both smFRET and FCS are single-molecule techniques that uniquely provide statistical
information on heterogeneous samples such as IDPs. Supplemental molecular detail from
NMR or cyro-EM, and confirmation of stoichiometry from AUC or affinity data from
calorimetry studies or SPR may further pinpoint differences between subclasses and
microstates. However, no technique to date can distinguish the whole suite of biophysical
parameters within a global ensemble. Furthermore, due to differing experimental
conditions between the aforementioned techniques, the measured conformational
ensembles may not be directly comparable between techniques, and observable
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differences between techniques simply reflect heterogeneous, environmentally sensitive
ensembles. This does not grant unique authority of one technique over another; instead a
full sampling of the range of IDP interactions informs on the entirety of the IDP
ensemble.
Scope of this work
Prior work within the field focused on tau-microtubule interactions, and utilized
tau constructs predominately isolated by enzymatic digestion of tau bound to
microtubules despite the demonstrated importance of the tubulin tails to tau binding and
their enzymatic susceptibility (45, 63, 147). Given that soluble tubulin unincorporated
into the microtubule lattice represents half of all cellular tubulin (148), understanding tautubulin interactions is critical for understanding the mass action of microtubule dynamics
in the presence of tau. NMR studies of tau binding to stathmin-stabilized tubulin
complexes have suggested specific regions in tau-tubulin binding interactions (65, 66).
However, in all these cases, tau-tubulin interactions were studied in the presence of other
stabilizing MAP constructs forming either artificially enforced tubulin interface surfaces
between two heterodimers or possibly obstructing tau binding sites. Of the available tautubulin information, the NTD isoforms were not studied, rather the MTBR isoforms (119)
– 2N4R and 2N3R – which combined represent only 7% of the cytosolic tau pool (88).
As the ratio of tau isoforms present has been proposed to influence tau-mediated
behavior, there is an obvious gap in the understanding of the NTD isoforms. The work
presented here specifically addresses the impact of the tau NTD isoforms on tau-tubulin
interactions. To reiterate, I chose smFRET since it is a single-molecule technique and a
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priori knowledge of bimodal populations of conformations within the tau-tubulin
ensembles is missing. One theory that the inserts themselves influence tau-tubulin
interactions is implied within in the literature (88, 91); if unique subpopulations exist
between NTD isoforms, smFRET may be able to distinguish them while also collecting
more broad coarse-grained information on the tau-tubulin conformational ensemble.
Here, I used a variety of dye positions expanding several regions to probe the
conformational ensembles of the NTD isoforms unbound and upon binding to soluble
tubulin. I used smFRET-derived RMSexp to identify a conserved, insert-independent
conformational ensemble within the NTD/PRR/MTBR regions in tau’s unbound state
(Chapter 2). Future studies using NMR for atomic resolution or advanced modeling from
molecular dynamic simulations may distinguish governing interactions between these
regions and possibly highlight more subtle differences between the isoforms.
To functionally probe these interactions between the NTD, PRR, and MTBR
systematically in a domain-centric and isoform-dependent manner, I used FCS to
measure binding of the NTD isoforms and tau fragments to soluble tubulin. Here, I
quantify the increase in diffusion time as tubulin is added to fluorescently labeled tau to
compare the variable binding between domains, as well as consider the varying degrees
of heterogeneity in the sizes of tau-tubulin species formed – a convoluted reflection of
both the affinity and degree of conformational heterogeneity within the tau-tubulin
complexes. Primarily due to novel construct design, I reveal unprecedented tight and
specific binding of the PRR region to soluble tubulin and demonstrated that PRR is
capable of polymerizing tubulin independent of the MTBR (Chapter 3). Together, my
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findings support an alternative model to other tau-mediated microtubule polymerization
models. Additional studies of PRR-microtubule interactions are ongoing. Given the tight
and specific interaction of PRR to tubulin, it is also a promising candidate for SPR
measurements to quantify a variety of biophysical parameters including kinetics and
confirmation of the FCS-determined stoichiometry.
Finally, with several collaborators, I sought to continue prior work comparing tautubulin and tau-microtubule interactions. We find there are differences in between tau’s
binding preference for GDP-tubulin over GMPCPP-tubulin within microtubule lattice
that cannot be recapitulated in solution (Chapter 4). This preliminary data suggests strain
along the lattice may regulate tau binding. Structurally, we used the environmentally
sensitive fluorophore acrylodan to probe the structure of the MTBR when bound to
soluble tubulin and compared our results with the recent cryo-EM structure (1), and
found the tau-tubulin and tau-microtubule interactions to be homologous throughout the
MBTR. However, PRR binding to the microtubule lattice was not resolved in the cryoEM structure (1). This led us to further investigate the role of tubulin tails to find a
dominating role in tau-tubulin binding (Chapter 4). PRR binding is significantly reduced
although not completely knocked down upon subtilisin digestion of the tubulin tails. This
suggests PRR binding is mediated in part through both the tubulin tails and the tubulin
body. Thus, tau-tubulin interactions may be capable of reading the tubulin ‘code’ in
solution as well as on the lattice through these two binding sites on the tubulin body and
the tails. Collectively, the work presented here opens many possibilities regarding
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regulatory interactions of microtubule dynamics governed by tau’s interdomain
interactions and their sampling of the tubulin binding sites.

CHAPTER 2: The N-terminal isoforms have a conserved
ensemble independent of sequence
This chapter is adapted from McKibben, K.M. and Rhoades, E., “Independent tubulin
binding and polymerization by tau’s proline rich region is regulated by its N-terminal
domain” (2019) 294(50) 19381-19394 J. Biol. Chem. doi:10.1074/jbc.RA119.010172
Introduction
Software packages and algorithms that model IDP behavior predict the projection
domain (NTD through P1) to be the most disordered region (149), and NMR spectra
demonstrate the NTD samples large regions of space while the P1 region is more
restricted (67). This large structural feature is thought to regulate binding to and spacing
of microtubules primarily through electrostatics. There are two models with the NTD
either acting as a ‘zipper’ by forming electrostatic contacts with the P1 or as an
electrostatic polyelectrolyte brush that compresses/expands in response to osmotic
pressure (11, 63, 74, 91, 92). It is additionally proposed to interact with other cellular
partners such as signaling proteins (150) and the plasma membrane (151). Within the
NTD, it contains two alternatively spliced inserts (N1 and N2). Isoform specific behavior
have been demonstrated to tune microtubule bundling (11, 63, 74, 91, 92), tau
aggregation propensity in a combinatorial manner with the MTBR isoforms (152), and
perhaps tau’s dwell time on stabilized microtubules thereby impacting MAP motor
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proteins (153). However, many of these comparative studies contrast 2N4R with 0N3R –
a simultaneous change in the number of binding sites within the MTBR. To date there
are only a few comparative studies of the NTD isoforms in which the MTBR isoform is
not also varied. Prior work on the NTD isoforms focused primarily on the differences in
bundling behavior, which scales well with the length of the N-terminal domain and is
electrostatically driven (11, 74, 91, 92). Subtle differences between KD and
polymerization kinetic parameters (specifically the time required to nucleate
polymerization) indicate that the NTD isoforms also weakly influence tau-mediated
polymerization kinetics (63). There are larger differences when the NTD is deleted,
resulting in large and tight bundling of stabilized microtubules (63).
Despite demonstrated NTD isoform-dependent tau-microtubule interactions, most
tau studies focus on the adult human 2N4R transcript in isolation which only comprises
~3% of the cytosolic tau pool (Chapter 1: Figure 1.1B) (88). To the best of my
knowledge, no studies on tau-tubulin interactions varying only the NTD isoforms have
been undertaken. It has been proposed the ratio of tau isoforms that dictate healthy tau
function rather than the precise isoform present (88). Understanding individual isoform
properties are critical to mapping emergent properties as a function of the various isoform
properties and ratios. Before complex studies of microtubule dynamics with mixed tau
isoform ratios can be undertaken, comparisons between the NTD isoforms are necessary
for understanding the underlying components of the tau isoform library.
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The global ensemble of tau is conserved across N-terminal isoforms
To probe the solution or unbound ensemble and the fully bound ensemble we first
verified saturated tubulin binding using fluorescence correlation spectroscopy (FCS)
using singly labeled tau constructs labeled at S433C (Fig. 2.1). These recombinant human
isoforms are referred to as tau2N, tau1N, and tau0N respectively to differentiate the
difference in isoforms from the difference between of labeling positions used throughout
this study. I also designed an artificial NTD isoform in which the second insert N2 was
present instead of N1 as in 1N4R to give tau1N*. In this way, we could probe the insertspecific properties of each isoform.
Prior work within the literature demonstrated small differences in the KD between
the N-terminal isoforms tau2N and tau1N upon binding to taxol-stabilized microtubules
(1.1 µM and 1.4 µM respectively) (63). Although not directly comparable, my FCS
measurements of tubulin binding by all three physiological N-terminal isoform variants,
tau2N, tau1N and tau0N, as well as by tau1N*, revealed their binding curves to be
comparable (Fig. 2.2) and fully saturated at 10 µM tubulin. See Appendix I: Experimental
Procedures for experimental details and Appendix II: Python Code for the analytical
handling of the FCS curves.
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Figure 2.1: Tau N-terminal constructs
The uppermost schematic is the longest tau isoform, tau2N. The domains and
corresponding residues that delineate them are marked: N-terminal domain (NTD) with
N-terminal inserts (N1, N2), proline-rich region (PRR) with sub-regions (P1, P2),
microtubule binding repeats (MTBR) with four imperfect repeat sequences (R1-R4)
flanked by the pseudo-repeat R' and the C-terminus. Below are the additional tau
isoforms and truncated variants used in this study. All numbering of residues throughout
the manuscript is based on tau2N. Nomenclature from (63) is in parenthesis for relevant
constructs. The corresponding amino acids for each construct with deletions subscripted
are given.

norm

1

0.5

tau2N
tau1N
tau1N*
tau0N

0
0

5

10

tubulin ( M)

Figure 2.2: Tubulin binding of the N-terminal isoforms
The increase in the normalized diffusion time, τnorm, as a function of tubulin
concentration reflects binding of fluorescently labeled tau to unlabeled tubulin. Data are
presented as mean ± SD, n≥3 independent measurements. See Appendix I.iii for details of
data analysis. See Table 2 for numerical values for τD and τnorm at 10 µM tubulin.
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In solution, the N-terminus of tau makes relatively close contacts with both the
MTBR and the C-terminus (118), which are lost when tau binds soluble tubulin (119). I
used smFRET to assess how the N-terminal inserts impact tau’s solution conformational
ensemble or bound state. Full-length tau isoforms were labeled with donor and acceptor
fluorophores at sites spanning domains of interest (Fig. 2.3A). The mean energy transfer
efficiencies (ETeff) were converted to experimental root-mean-square (RMSexp) distances
using a Gaussian coil model (see Appendix I.iv for details). For constructs probing the Cterminus, tau291-433, as well as the PRR, tau149-244, all three isoforms gave rise to
comparable RMSexp values (Fig. 2.3B and Table 2.1); this was expected, as the number of
residues encompassed by the probes is the same for all three isoforms. The constructs
probing the N-terminal domain (NTD), tau17-149, also exhibited predicted behavior in that
the presence of each N-terminal insert resulted in an increase in the RMSexp (Fig. 2.3B
and Table 2.1).
Interestingly, constructs whose labels span the NTD through the PRR, tau17-244,
or the NTD through part of the MTBR, tau17-291 had comparable ETeff histograms, and
thus RMSexp values, in solution, despite an increase of up to 60 residues between
isoforms (Fig. 2.3B and Table 1). Similarly, the RMSexp values for the constructs probing
the entirety of the isoforms, tau17-433, were also nearly equivalent; this is consistent with
our observations of comparable RMSexp values for the subdomain constructs – tau17-291
and tau291-433 – which make up tau17-433 (Fig. 2.3B and Table 2.1). The similar interdomain distances suggest homologous conformational ensembles between isoforms.
Moreover, the ensembles for tau17-244 and tau17-291 are significantly more compact than
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expected for a random coil. To illustrate, the RMSexp values of the tau17-291 isoforms are
of similar magnitude to those of tau149-244 despite being 120 to 180 residues longer (Fig.
2.3B and Table 2.1). Furthermore, the dimensions of tau149-244 are close to values
predicted for a random coil of an equivalent number of residues (gray dashed line in Fig.
2.3B,C; values calculated in Table 2.1), such that despite encompassing this very
expanded region, tau17-244 and tau17-291 constructs are very compact. Upon binding to
tubulin, deviations from scaling behavior were diminished, and all constructs yielded
RMSexp values that scale with the number of residues in a manner consistent with an
extended, random structure (Fig. 2.3C and Table 2.1) (1, 67, 119).
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Figure 2.3: SmFRET of tau N-terminal isoforms
(A) Schematic of reference construct tau2N with residues labeled for smFRET
measurements indicated. (B) SmFRET histograms of tau2N, tau1N, tau1N* and tau0N in the
absence (dark, left axis) and presence (light, right axis) of 10 µM tubulin. Labeling
positions are indicated at the top of each column. The histograms are fit to a sum of
Gaussian distributions to determine the mean ETeff as detailed in the Appendix I.iv.
Measurements were carried out in phosphate buffer pH 7.4 at 20° C. (C) The root-meansquare distances (RMS) between labeling positions calculated from a Gaussian chain
model (RMSexp) are plotted in the absence (left) and presence (right) of 10 µM tubulin
(154). Shaded regions on this plot indicate RMSexp that are too large to be determined
accurately by the Alexa 488-Alexa 594 fluorophore pair. For reference, the RMS
calculated for a random coil (RMSRC) as in Reference (155) is indicated by the gray
dashed line. Data are presented as mean ± SD, n≥3 independent measurements. See Table
2.1 for numerical values of ETeff ± SD, RMSexp ± SD and RMSRC for each construct.
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Table 2.1: Summary of SmFRET biophysical data of tau N-terminal isoforms
All numbering throughout the manuscript is based on tau2N. Unless otherwise noted, all
constructs contain C291S and C322S mutations. Labels identifies the residues mutated to
cysteines for site-specific labeling. Mean ETeff values from fits to histograms as shown in
Fig. 2.2 from measurements in the absence and presence of 10 µM tubulin. Values are
mean ± SD for ≥3 independent measurements of 20-40 pM tau in phosphate buffer pH
7.4 at 20 °C. RMSexp calculated from mean ETeff values as described in the Appendix I.iv
and RMSRC calculated from the theoretical random coil model for the number of residues
noted (155).
isoform

tau2N

tau1N

tau1N*

tau0N

8

labels

ETeff

# residues

RMSexp (Å)

- tubulin

+ tubulin

- tubulin

+ tubulin

RMSRC (Å)

17

433

417

0.27 ± 0.02

0.10 ± 0.01

88 ± 3

134 ± 2

181

17

291

275

0.52 ± 0.02

0.11 ± 0.02

62 ± 1

129 ± 6

141

17

244

228

0.62 ± 0.01

0.11 ± 0.01

52 ± 1

127 ± 2

126

17

149

133

0.48 ± 0.01

0.25 ± 0.01

64 ± 1

92 ± 1

91

149

244

96

0.43 ± 0.01

0.39 ± 0.01

68 ± 1

72 ± 1

75

291

433

143
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Electrostatic interactions between domains drive ensemble formation
The comparable ETeff values for tau17-244 and tau17-291 constructs, irrespective of
the number of N-terminal inserts, suggested conserved interactions within the
NTD/PRR/MTBR that were not strongly dependent upon sequence.

To test this, I

deleted the N1 insert from tau2N to create tau1N* (Fig. 2.1). As expected, the ETeff values
and, consequently, the calculated RMSexp values for tau17-149, tau149-244 and tau291-433
constructs of tau1N* were all comparable to those of the physiological isoforms (Fig. 2.2B
and Table 2.1). Consistent with our hypothesis, smFRET measurements of tau17-244, tau17291

and tau17-433 constructs of tau1N*, gave rise to RMSexp values comparable to those

measured for the same constructs of tau0N, tau1N and tau2N (Fig. 2.3B and Table 2.1). As a
whole, my data demonstrate that the conserved ensemble within the NTD/PRR/MTBR
are not insert dependent, but arise from a more general interaction mechanism within
these domains. Both the MTBR and the PRR carry a positive net mean charge while the
NTD that carries a negative net mean charge regardless specific isoform (Table 2.3B and
Table 2.1).
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Table 2.2: Charge profile of individual tau domains
The net charge is the number of positively charged residues minus the number of
negatively charged residues for each domain listed, calculated at pH 7.4 using Sequence
Manipulation Suite (156). The mean net charge is the net charge divided by the number
of residues for each domain.
domain

# residues

net charge

mean net charge

NTD2N

149

-21

-0.14

NTD1N

119

-18

-0.15

NTD1N*

120

-13

-0.11

NTD0N

90

-10

-0.11

PRR

94

14

0.15

MTBR

125

9

0.07

MTBR-R'

152

12

0.08

C-terminus

44

-3

-0.07

One feasible explanation is that attractive electrostatic interactions between the NTD and
the PRR/MTBR result in a compact ensemble that is largely independent of the inserts
themselves. These interactions between the negatively charged NTD and the positively
PRR/MTBR are effectively neutralized upon binding to tubulin, another negatively
charged particle, causing the tau ensemble to open up becoming a Gaussian coil.
Discussion
Presented here to the best of my knowledge, is the first comparative structural
study of the N-terminal isoforms bound to soluble tubulin. Prior NMR studies of fulllength tau to stabilized microtubules, have shown the NTD does not strongly interact with
microtubules and retains a heterogeneous conformation in solution that makes transient
long range contacts with other domains (67). Prior work from our lab on 2N4R and 2N3R
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similarly demonstrated long-range contacts between the NTD and the other tau regions
that are disrupted upon binding to soluble tubulin (119). In both studies, only the 2N Nterminal isoform was studied. In this work, I used smFRET to compare the N-terminal
isoforms global interdomain interactions in an insert-specific manner. Demonstrated here
is the conserved global ensemble between the NTD and the PRR/MTBR across all Nterminal isoforms in an insert-independent manner driven primarily by electrostatics. I
find the NTD of tau2N deviates equally from the predicted random coil sampling as the
MTBR in solution; the only region that scales as predicted is the PRR, indicating the
majority of tau’s regions are compacted under my experimental conditions. It is only
upon binding to soluble tubulin does the NTD, as well as all the other probed regions,
reproduce predicted random coil ensembles (149). Subtle structural differences between
the isoforms do exist; however, it is important to remember the coarse-grained nature of
this structural information, the anticipated difference of losing/gaining 30 amino acids per
insert, and the wide distribution of possible states being averaged within the reported
RMSexp. This compact global ensemble between the NTD/PRR/MTBR is remarkably
unchanged upon the addition or removal of the NTD inserts N1 and N2 despite a 20%
increase/decrease in amino acid length with each insert. This suggests an overall
conserved,

electrostatically

based

mechanism

driving

the

formation

of

this

conformational ensemble with potentially a corresponding biological function. As these
interdomain interactions are disrupted upon binding to tubulin, it is possible the NTD
may regulate tau-tubulin interactions indirectly by either generally screening the
negatively charged incoming tubulin – effectively guarding both the binding regions and
flanking regions – or may transiently sample the regions within the PRR/MTBR thereby
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temporarily weakening the tau-tubulin binding interaction indirectly. Speculatively, the
combination of NTD with MTBR isoform (for example, 2N4R and 0N3R) would have
altered interactions between the NTD and the MTBR, and the corresponding global
ensemble would be more expanded or heterogeneous within 0N3R as both domains
would have weakened screening capacity. If certain regions with stronger interactions
between the NTD and MTBR exist, then a combinatorial effect on the global ensemble
would also be possible.

CHAPTER 3: Independent binding and polymerization of the
proline rich region is negatively regulated by the N-terminal
domain
This chapter is adapted from McKibben, K.M. and Rhoades, E., “Independent tubulin
binding and polymerization by tau’s proline rich region is regulated by its N-terminal
domain” (2019) 294(50) 19381-19394 J. Biol. Chem. doi:10.1074/jbc.RA119.010172
Introduction
The conservation of the conformational ensembles across N-terminal isoforms
suggests a functional origin. This led me to examine the impact of the N-terminal inserts
on tau binding to soluble tubulin. Despite intense interest in tau, the molecular details of
its numerous proposed functions remain relatively obscure. This is in part due to the
challenges that arise from its lack of stable structure (157), and that it does not form welldefined stoichiometric complexes with tubulin (58). To illustrate, it was demonstrated
more than 20 years ago that P2 (63, 64, 93) greatly enhanced tau binding to microtubules
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and its ability to polymerize tubulin (59), yet this region of tau is not observed in a recent
structure of microtubule-bound tau (1). It may be that P2 enhances binding indirectly
through interactions with the MTBR (93), or that bound P2 is too disordered and dynamic
on the microtubule surface to be resolved by EM. These apparently diverging
observations, and the need to reconcile them, highlights the requirement for studies of tau
function that look beyond the MTBR.
Here, I investigate the role of the NTD and PRR in regulating tau’s interactions
with soluble tubulin. FCS of the full-length and tau variants were used to monitor binding
in tau:tubulin assembles. We found that in the absence of tubulin, the NTD interacts with
the PRR and MTBR through a conserved conformational ensemble. The NTD negatively
regulates binding to soluble tubulin and subsequently slows polymerization. Strikingly,
we find that the isolated PRR is capable of both stoichiometric binding to, and
polymerization of, soluble tubulin. The presence of the NTD dramatically reduces the
binding and polymerization capacity of the PRR. Based on our results, we propose a
model where the PRR serves as a core tubulin binding domain of tau, with both binding
and polymerization capacity enhanced by the MTBR and R', and reduced by the NTD.

8

53

Figure 3.1: Schematic of tau constructs
The uppermost schematic is the longest tau isoform, tau2N. The domains and
corresponding residues that delineate them are marked: N-terminal domain (NTD) with
N-terminal inserts (N1, N2), proline-rich region (PRR) with sub-regions (P1, P2),
microtubule binding repeats (MTBR) with four imperfect repeat sequences (R1-R4)
flanked by the pseudo-repeat R' and the C-terminus. Below are the additional tau
isoforms and truncated variants used in this study. All numbering of residues throughout
the thesis is based on tau2N. Nomenclature from (63) is in parenthesis for relevant
constructs. The corresponding amino acids for each construct with deletions subscripted
are given.
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Tau’s NTD negatively regulates tubulin binding
Tubulin binding was assessed by FCS under non-polymerizing conditions.
Fluorescently labeled tau was measured in the presence of increasing concentrations of
tubulin. Both the longest full-length isoform, tau2N, and an NTD deletion fragment, tau∆N
(amino acids 148 to 441), bound tubulin as seen by an increase in the normalized
diffusion time, τnorm, with increasing tubulin concentration (Fig. 3.2 and Table 3.2).
However, there are significant differences in the binding curves; tau2N reached its
maximum τnorm at ~2.5 µM tubulin, while the τnorm for tau∆N continued to increase. At 10
µM tubulin, the τnorm of tau∆N was more than 2x larger than that of tau2N (Fig. 3.2). This
effect was specific to the NTD. Binding by a C-terminal deletion construct, tau∆C (amino
acids 1 to 395), resembled that of tau2N (Fig. 3.2) while a combined N-terminal and Cterminal deletion construct, PRR-MTBR-R' (amino acids 148 to 395) behaved like tau∆N
(Fig. 3.2). These measurements suggest that the NTD of tau reduces or negatively
regulates its binding to soluble tubulin, while the C-terminus does not have a significant
role.
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tau2N
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tau N

norm

3

1.5

0
0

5

tubulin (µM)
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Figure 3.2: Inhibition of tubulin binding by the NTD
The increase in the normalized diffusion time, τnorm, as a function of tubulin
concentration reflects binding of fluorescently labeled tau to unlabeled tubulin. All
measurements were carried out in phosphate buffer pH 7.4 at 20° C. Data are presented
as mean ± SD, n≥3 independent measurements. See Appendix A1.iii for details of data
analysis. See Table 3 for numerical values for τD and τnorm at 10 µM tubulin, as well as the
labeling position for each construct.

The τnorm values measured at 10 µM tubulin for constructs lacking the NTD are
significantly greater than those including this domain, ~2.7 ms as compared to ~1 ms,
with a larger spread in the diffusion times sampled (Fig. 3.3). It was demonstrated tau
forms fuzzy complexes with soluble tubulin consisting of multiple, weakly-associated
tubulin dimers that positively correlate the rate of tau-mediated polymerization of tau
fragments (58). Using a similar approach as described in that work, we analyzed the
individual autocorrelation curves of tau2N and PRR-MTBR-R' taken in the presence of 10
µM tubulin in order to assess the heterogeneity of the tau-tubulin complexes (Fig. 3.3;
details of analysis are in the Appendix I.iii). From this analysis, it was apparent that not
8
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only were tau:tubulin complexes formed by PRR-MTBR-R' on average larger (median
diffusion time, τmedian=2.02 ms) than those formed by tau2N (τmedian=1.29) but that PRRMTBR-R':tubulin complexes also had the largest spread in diffusion times (1.26 to 2.89
ms). These complexes persisted at 300 mM KCl, indicating they were not only present in
low salt buffer (Table 3.2). Analysis of the average brightness, counts per molecule
(CPM), of the diffusing species demonstrated that while tau2N typically consisted of a
single tau molecule, the PRR-MTBR-R':tubulin complexes, especially the larger ones,
may have included several tau molecules (Fig. 3.3 and Table 3.3).

Figure 3.3: Regulation of the tau:tubulin complex heterogeneity by the NTD
(A) Individual autocorrelation curves (gray dots) are plotted for tau2N (right) and PRRMTBR-R' (left) in the presence of 10 µM tubulin. Averaged curves are shown with
colored dots and fits of the averaged curves to Eq. 2 are in black. Data plotted represent
all collected curves from independent triplicate measurements measured on different
days. (B) The autocorrelation curves from (A) were individually fit to obtain a
distribution of τD and CPM (kHz) values. When the NTD is absent, larger tau-tubulin
complexes form as seen by the larger values of τD containing additional tau molecules as
seen by the increase in CPM (kHz). Measurements were carried out in phosphate buffer
pH 7.4 at 20° C. See Table 3.3 for labeling positions of constructs.
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As observed for tau2N, analysis of the individual autocorrelation curves of tau1N,
tau1N* and tau0N demonstrates that these isoforms also form smaller tau:tubulin
complexes than PRR-MTBR-R' (Fig. 3.4C and Table 3.3), containing only a single tau
(Fig. 3.4D and Table 3.3). Analysis of diffusion times and brightnesses of the complexes
suggest that the NTD limits both: (1) the average number of tubulin dimers bound to a
single tau molecule; and (2) the average number of tau bound to a single tubulin dimer. I
explicitly tested for sequence specificity in the NTD’s regulation of tubulin binding by
scrambling the sequence of the N1/N2 inserts, while retaining a distribution of charged
and hydrophobic residues similar to the N1/N2 wild-type sequence, tau2Nscr (Fig. 3.4A).
As predicted, both the tubulin binding curve as well as the heterogeneity analysis of
tau2Nscr are comparable to tau2N (Fig. 3.4A, Tables 3.2 and 3.3). Along with my smFRET
measurements, these data support a model whereby regulation of tubulin binding by the
NTD is sequence and insert independent, likely arising from general electrostatic
interactions between the NTD and the PRR/MTBR.
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Figure 3.4: Impact of the NTD inserts N1 and N2 on binding
(A) To test the sequence-dependence of the WT N-terminal inserts, we scrambled the
insert sequences (tau2Nscr) while preserving the IDP character of the region by equivalent
mixing of hydrophobic and charges residues (111). (B) The increase in the normalized
diffusion time, τnorm, as a function of tubulin concentration reflects binding of
fluorescently labeled tau to unlabeled tubulin. Data are presented as mean ± SD, n≥3
independent measurements. Measurements were carried out in phosphate buffer pH 7.4 at
20 ºC. See Appendix I.iii for details of data analysis. See Table 3.3 for numerical values
for τD and τnorm at 10 µM tubulin. Average tau2N from Fig. 3.2 are replotted for
comparison. Scrambling the sequences of the N-terminal inserts does not change the
binding behavior. (C) The autocorrelation curves for tau2N, tau1N, tau1N*, tau0N, tau2Nscr,
and PRR-MTBR-R' in the presence of 10 µM tubulin were individually fit to obtain a
distribution of τnorm values. Each individual τD was converted to τnorm by the average τD of
each independent measurement (Table 3.3). When the NTD is absent, larger tau-tubulin
complexes form as seen by the larger values of τnorm. (D) The corresponding distributions
of CPM (kHz) from the fits of autocorrelation curves in (B) of tau2N, tau1N, tau1N*, tau0N,
tau2Nscr and PRR-MTBR-R' in the presence of 10 µM tubulin. When the NTD is absent,
an increase in the number of tau molecules associated to the tau:tubulin assemblies is
reflected in the increase in CPM. Overlays in both (B) and (C) are lognormal
distributions. See Table 3.2 for labeling positions of constructs and Table 3.3 for
descriptive statistics of distributions. Measurements were carried out in phosphate buffer
pH 7.4 at 20° C. See Appendix I.iii for details of data analysis.
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In order to determine a relationship between tubulin binding and polymerization
of these constructs, the polymerization capacity of each construct was quantified. PRRMTBR-R' had the fastest polymerization half-time (t1/2=52 ± 7 s) while the full-length
isoforms, including tau1N* were all slower (Fig. 3.5). This observation is in good
agreement with prior work, where deletion of the NTD from various constructs led to
small increases in polymerization rates (63). Interestingly, tau2N was the slowest (t1/2=137
± 9 s), lagging behind tau1N, tau1N* and tau0N (t1/2=85 ± 5 s, 88 ± 13 s and 76 ± 10 s,
respectively and within error of each other) (Fig. 3.5 and Table 3.1). Thus, while the
presence of any part of the NTD has the largest effect on binding and polymerization, the
presence of both native inserts may enhance the inhibitory interactions between the NTD
and PRR/MTBR. Minor differences in multiple microtubule dynamic parameters have
been noted previously for tau2N and tau0N, both in vivo and in vitro (64, 158).
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Figure 3.5: Impact of the NTD inserts N1 and N2 on polymerization
Tubulin polymerization as measured by scattered light at 340 nm as a function of time.
Measurements were made in phosphate buffer pH 6.9 with 1 mM GTP at 37 °C with 5
µM tau and 10 µM tubulin. See Table 3.1 for fit parameters. Data are presented as mean
± SD following normalization, n=3 independent measurements. See Appendix I.vii for
details of data analysis. Arrows indicate depolymerization at 4 °C.

The PRR independently binds and polymerizes tubulin
The reduced binding of NTD containing constructs (Figs. 3.2-4) coupled with the
conserved conformational ensembles in the NTD/PRR/MTBR constructs observed in the
smFRET measurements (Chapter 2), led me to hypothesize that the NTD may regulate
tubulin binding though interactions with the PRR or MTBR. To investigate this
hypothesis, I created constructs corresponding to these domains and measured binding by
FCS as well as tau-mediated polymerization. Although the MTBR (amino acids 244-372)
associates with microtubules in the context of the full-length protein or in constructs
containing P2 (1, 60), the isolated domain bound only weakly to soluble tubulin (Fig.
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3.6A) and was not capable of polymerizing tubulin (Fig. 3.6B). The addition of R',
MTBR-R' (amino acids 244-395), enhanced binding (Fig. 3.6A) but still did not yield a
construct that promoted efficient polymerization (Fig. 3.6B). Early studies demonstrated
that the MTBR-R' (63) or even peptides corresponding to the individual MTBR repeats
(159) had weak polymerization capacity, although 5 to 10-fold more tau was required
than the 10 µM used here.
Strikingly – and surprisingly – the isolated PRR (amino acids 148-244), bound
tubulin tightly when compared to the MTBR and MTBR-R' measured under the same
conditions (Figs. 3.6A,B). Similarly, PRR exhibited a higher affinity for taxol-stabilized
microtubules in comparison to MTBR-R' (Fig. 3.6C). While P2 has been identified as
enhancing binding and accelerating polymerization in vitro when coupled to the MTBR
(63, 64, 93, 95) independent polymerization capacity for PRR has not been reported
previously. Rather, the opposite conclusion was reached by one study – namely, that the
PRR is not capable of strong, independent assembly of microtubules (93). More recent
work demonstrated binding of a PRR-like construct (amino acids 166-246) to both
stathmin-complexed tubulin and taxol-stabilized microtubules with 1:2 stoichiometry
(65). However, the polymerization capacity of this construct was not tested.
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Figure 3.6: Independent polymerization capacity of the PRR, regulated by the NTD
Figure S4. PRR and MTBR-R' bind taxol-stabilized microtubules. Taxol-stabilized microtubules were re-
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nM. (B) Tubulin polymerization as measured by scattered light at 340 nm as a function of
time. Measurements were made in phosphate buffer pH 6.9 with 1 mM GTP at 37 °C
with 10 µM tau and 10 µM tubulin. See Table 3.1 for fit parameters. Data are presented
as mean ± SD following normalization, n=3 independent measurements. Arrows indicate
depolymerization at 4 °C. (C) Taxol-stabilized microtubules were re-suspended in
phosphate buffer pH 6.9 and then incubated at room temperature for 10 minutes with 1
µM PRR or MTBR-R' labeled with Alexa Fluor 488 prior to separation of bound and free
tau by ultracentrifugation to pellet microtubule-associated tau. Coomassie (right) and
Alexa Fluor 488 fluorescence (left) images supernatant (S) and Pellet (P) were analyzed
to yield ~70% MTBR-R' and ~95% PRR bound to microtubules. The tau-only loading
control is also shown. The band at approximately 50 kDa is the composite unresolved
bands of α and β monomer tubulin subunits; the bands at ~25 kDa and 18 kDa are
MTBR-R' and PRR, respectively.
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NTD negatively regulates the polymerization capacity of the PRR
Our observation that the PRR binds to and polymerizes tubulin independently of
the MTBR (Fig. 3.6A), combined with the slower polymerization rate of tau constructs
including the NTD (tau2N, tau1N, tau1N* and tau0N) relative to PRR-MTBR-R' (Figs. 3.5),
motivated us to determine the impact of the NTD on interactions of the PRR with tubulin.
Tau2N was truncated after the PRR at amino acid 244 (2N-PRR), and binding to soluble
tubulin and polymerization capacity were measured. The presence of the NTD
dramatically reduced binding (Fig. 3.6A) as well as significantly diminished tubulin
polymerization capability (Fig. 3.6B). Truncated constructs based on tau0N, 0N-PRR, and
tau1N*, 1N*-PRR, showed similar binding behavior (Fig. 3.7).
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Figure S8. Impact of N-terminal inserts on the binding of PRR. The τnorm of tau constructs 1N-PRR and 0N-PRR
are plotted
against 3.7:
increasing
tubulin concentration.
Tau constructs
PRR and
are re-plotted
Fig. 4A for
Figure
Impact
of N-terminal
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on2N-PRR
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offrom
PRR
comparison. Data are presented as mean ± SD, n≥3 independent measurements. See Experimental Procedures for
details of data analysis. See Table S5 for numerical values for τD and τnorm at 10 µM tubulin.
τnorm of tau constructs 1N*-PRR and 0N-PRR are plotted against increasing tubulin

The
concentration. Tau constructs PRR and 2N-PRR are re-plotted from Fig. 3.6A for
comparison. Data are presented as mean ± SD, n≥3 independent measurements.
Measurements were carried out in phosphate buffer pH 7.4 at 20 °C. See Appendix I.iii
for details of data analysis. See Table 3 for numerical values for τD and τnorm at 10 µM
tubulin.
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Collectively, these results led us to propose that the binding and – by extension –
polymerization capacities of tau are regulated by interactions between the NTD and the
PRR, evident by the conserved ensembles observed with smFRET for this domain (tau17244

in Chapter 2). Because the conserved ensembles extend into the MTBR (tau17-291 in

Chapter 2), we tested this idea by making a construct lacking the PRR (2N-MTBR-R'
amino acids 1 to 148 fused to 245 to 395). This construct also did not demonstrate
appreciable binding to tubulin (Fig. 3.6A), while that same construct lacking the NTD
(MTBR-R') clearly did (Fig. 3.6A). As may be expected based on its weak binding to
soluble tubulin, 2N-MTBR-R' was also not polymerization competent (Fig. 3.6B). As a
whole, these results strongly support a functional, regulatory role for the compact, albeit
disordered, NTD/PRR/MTBR ensembles observed by smFRET in Chapter 2.
Table 3.1: Tau-mediated polymerization
Polymerization half-times (t1/2) for tau constructs shown in Figs. 5 and 6. Values listed
for t1/2 are mean ± SD for n = 3 independent measurements. NA indicate constructs tested
but that did not measurably polymerize underneath assay conditions. The tubulin
concentration was held constant at 10 µM across all polymerization experiments with the
tau concentration varied according to the table below. Polymerizations were carried out
in phosphate buffer pH 6.9 with 1 mM GTP at 37 °C.
construct
PRR-MTBR-R'
tau2N
tau1N
tau1N*
tau0N
PRR
2N-PRR
MTBR
MTBR-R’
2N-MTBR-R’

8

t1/2 (s)
52 ± 7
137 ± 9
85 ± 5
88 ± 13
76 ± 10
96 ± 55
NA
NA
NA
NA

65

[tau] (µM)
5
5
5
5
5
10
10
10
10
10

The formation of bone-fide microtubules was confirmed using tunneling electron
microscopy (Fig. 3.8). Mixtures of PRR, 2N-MTBR-R’, and PRR-MTBR-R’ of
completed polymerization reactions from Fig. 3.5 and 3.6 were incubated with taxol prior
to imaging. Using this more sensitive technique, we were able to observe small amounts
of microtubule-like structures formed by 2N-MTBR-R’. This is in agreement with older
in vitro studies that observed tau-mediated polymerization of the MTBR region repeats at
much higher concentrations (159). It should be noted, however, these structures do not
represent the majority of the TEM grid nor do they resemble canonical microtubules.
Also in agreement with previous studies, PRR-MTBR-R’ forms large bundles of
microtubules. The varying morphology of PRR and 2N-MTBR-R’ warrants further study;
currently, the data speculatively suggests PRR is responsible for tau-tubulin interactions
which favor straight unbundled, microtubules.
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Figure 3.8: PRR encourages the formation of straight microtubules
TEM images of microtubules formed by tau-tubulin polymerization reactions as in Figs.
3.5 and 3.6: (A) PRR; the region outlined in white in the left-hand panel is shown at
higher-magnification in the center left panel. (B) tubulin-only control (C) 2N-MTBR-R’;
representative blank field with 2N-MTBR-R’ present (left) and example of microtubulelike structures also infrequently found (right) (D) PRR-MTBR-R’ formed microtubule
bundles.

PRR forms tight, saturable tau:tubulin complexes
Furthermore, unlike constructs where the PRR is coupled with the MTBR and/or
R', such as PRR-MTBR or PRR-MTBR-R', the PRR demonstrated saturable binding and
did not form large tau:tubulin complexes (Figs. 3.3 and 3.9). As a consequence, unlike
the binding curves of the PRR-MTBR and PRR-MTBR-R', the PRR binding curves can
be meaningfully fit with Hill equation:
Eq. 1

where

is the normalized diffusion time for tau:tubulin measured at 10 µM tubulin,

n is the Hill coefficient and reflects the extent of cooperativity, KD is the apparent
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dissociation constant and [tub] is the concentration of tubulin dimer. Fitting the
PRR:tubulin binding curve to the Hill equation yields n=1.7 ± 0.2 and with an apparent
KD ≈ 900 nM (Fig. 3.6A). In our previous work, the engineered protein construct RB3,
which binds tubulin with 1:2 RB3:tubulin dimer stoichiometry was used to determine the
expected τD of a 1:2 protein:tubulin dimer complex (58, 160). Here, the τD measured for
the PRR at 10 µM tubulin (0.82 ± 0.03 ms) is consistent with a 1:2 tau:tubulin dimer
stoichiometry. This observation, coupled with the cooperativity seen in Hill equation fit,
strongly supports the presents of two tubulin-dimer binding sites in the PRR. This
apparent specificity suggests that formation of tau:tubulin fuzzy complexes arises
primarily from the collective binding properties of the PRR and MTBR-R'. Additional
biophysical studies such as NMR to determine kinetic parameters or AUC confirm the
stoichiometry via a complementary method may be beneficial for future studies.

8

68

- tubulin

G( )

PRR

A

+ tubulin

0.04

0.04

0.02

0.02

0

0
10-3

1

103

10-3

1

103

1

103

G( )

PRR-MTBR-R'

0.5
0.04
0.3
0.02
0.1
0
10-3

1

103

10-3

time (ms)

time (ms)

4
PRR-MTBR-R'
plottedP1
for PRR (upper) and PRR-MTBR-R'
(lower) in the absence (left) or presence (right) of 10 µM tubulin.
P2
MTBR
Averaged
curves are shown with blue dots PRR
and fits of the averaged curves to Eq. 2 are in black.
3

norm

norm

1
S9. HeterogeneityBin tubulin-bound
PRR-MTBR-R'. Individual autocorrelation curves (gray dots) are
A Figure
B
PRR

0.5

2
1
0

0
0

5

tubulin ( M)

10

0 0.25 0.5 0.75 1

2

3

tubulin ( M)

5

7

10

7. The PRR forms stoichiometric complexes with tubulin. A, Binding of tau constructs to
3.9: The
forms stoichiometric
complexes with Data
tubulinare presented as
as measured by an increaseFigure
in τnorm
as aPRR
function
of tubulin concentration.
SD, n≥3 independent
P1 andcurves
P2 bind
or stronger
(A) measurements.
Individual autocorrelation
(grayonly
dots) weakly,
are plottedbut
for are
PRRcomparable
(upper) and PRRTBR. Measurements
were(lower)
madeininthephosphate
buffer
pH 7.4
at of2010°C.
See Table
3 for labeling
MTBR-R'
absence (left)
or presence
(right)
µM tubulin.
PRR-MTBRwascomparison,
replotted from Fig.
3.3 for
comparison.
curves are from
shown with
dots B, The
s of constructs. R'
For
PRR
and
MTBRAveraged
are replotted
Fig.blue
6A.
and fits of the averaged curves to Eq. 2 are in black. Measurements were made with 20
elation curves for nM
PRR
and PRR-MTBR-R' were individually fit to obtain a distribution of τnorm
PRR or PRR-MTBR-R' and 10 µM tubulin in phosphate buffer pH 7.4 at 20 °C. (B)
t each tubulin concentration.
Each curves
individual
τDand
was
converted to
τnorm
by the fit
average
The autocorrelation
for PRR
PRR-MTBR-R'
were
individually
to obtainτDa of each
dent measurementdistribution
(Table of3).τnormUnlike
PRR-MTBR-R'
which forms
tubulin-concentration
values at
each tubulin concentration.
Each individual
τD was
to τnorm
by the averageexceeding
τD of each ~1
independent
measurement
3.3).
nt large complexesconverted
at tubulin
concentrations
µM tubulin,
PRR (Table
binding
saturates
Unlike PRR-MTBR-R' which forms tubulin-concentration dependent large complexes at
s not form large complexes. Data plotted represent all collected curves from independent triplicate
tubulin concentrations exceeding ~1 µM tubulin, PRR binding saturates and does not
ments on measuredform
on different
days. See
details
data analysis.
large complexes.
Data Experimental
plotted representProcedures
all collected for
curves
fromofindependent
S10

triplicate measurements on measured on different days. See Appendix I.iii for details of
data analysis.
8

69

Tight binding of the PRR to tubulin required the presence of both proline rich
regions; fragments corresponding to P1 (amino acids 148 to 198) or P2 (amino acids 199
to 244) bound tubulin only weakly (Fig. 3.10A). Interestingly, a prior study noted that
while a P2-MTBR-R' construct lacked microtubule bundling capacity, the addition of P1
to this construct conferred this ability (63), reflecting a similar enhancement in the
interaction with stabilized microtubules that we find with soluble tubulin. One reason
independent function of the PRR has been overlooked may be in part due to the
widespread use of the K16 fragment consisting of P2 and the 4R MTBR (amino acids
198 to 372, P2-MTBR) (63). By FCS, the P2-MTBR construct binds to tubulin, however,
it does not bind as many tubulin dimers at high tubulin concentrations as PRR-MTBR
(Fig. 3.10B). Thus, while the isolated P1 does not bind tubulin strongly (Fig. 3.10B), it
does enhance binding and contribute to tau function.
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Figure 3.10: P1 and P2 dependence of PRR binding
(A) Binding of tau constructs to tubulin as measured by an increase in τnorm as a function
of tubulin concentration. Data are presented as mean ± SD, n≥3 independent
measurements. The PRR data is fit with the Hill Equation (orange line; Eq. 1) yielding
n=1.7 ± 0.2 and with an apparent KD ≈ 900 nM. P1 and P2 bind only weakly, but are
comparable or stronger than, MTBR. (B) The τnorm of tau constructs PRR-MTBR and P2MTBR measured by FCS are plotted against increasing tubulin concentration. Data are
presented as mean ± SD, n≥3 independent measurements. Measurements were carried out
in phosphate buffer pH 7.4 at 20 °C. See Appendix I.iii for details of data analysis. See
Table 3 for numerical values for τD and τnorm at 10 µM tubulin.
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Table 3.2: Summary of FCS biophysical data of tau isoforms and constructs
All numbering throughout the manuscript is based on tau2N. Unless otherwise noted, all
constructs contain C291S and C322S mutations. CFCS is the residue number mutated to
cysteine for labeling for FCS measurements. Diffusion times (τD) of tau constructs in the
absence and presence of 10 µM tubulin. CPMnorm is the average CPM of labeled tau in the
presence of tubulin divided by CPM of labeled tau without tubulin. Values are mean ±
SD for n ≥ 3 independent measurements. Each measurement is the fitted average of
multiple FCS curves from 15-25 nM tau incubated with 10 µM tubulin in phosphate
buffer pH 7.4 at 20 °C. (*) Indicates measurements with 300 mM KCl. The τnorm is
calculated as described in the Appendix I.iii.
Construct

τnorm (ms)

CPM (kHz)

CPMnorm (kHz)

- tub

+ tub

+ tub

- tub

+ tub

+ tub

tau2N

433

0.80 ± 0.03

1.54 ± 0.09

0.92 ± 0.09

11 ± 4

15 ± 2

1.3

tau1N

433

0.76 ± 0.01

1.51 ± 0.16

0.87 ± 0.24

12 ± 1

15 ± 1

1.3

tau1N*

433

0.78 ± 0.03

1.53 ± 0.14

0.96 ± 0.14

12 ± 1

15 ± 2

1.3

tau0N

433

0.79 ± 0.02

1.57 ± 0.12

1.00 ± 0.12

12 ± 1

18 ± 2

1.5

433

0.78 ± 0.01

1.49 ± 0.09

0.92 ± 0.09

12 ± 1

16 ± 1

1.3

0.78 ± 0.02

2.71 ± 0.73

2.48 ± 0.73

18 ± 2

35 ± 8

1.9

0.79 ± 0.05

1.51 ± 0.15

0.92 ± 0.15

9±1

16 ± 3

1.7

tau2Nscr
tau∆N
tau∆C

8

τD (ms)

CFCS

433
17

2N

17

0.53 ± 0.07

0.53 ± 0.06

-0.01 ± 0.06

7±1

8±1

1.1

PRR

149

0.47 ± 0.01

0.82 ± 0.03

0.75 ± 0.03

9±1

9±1

1.0

MTBR

322

0.50 ± 0.02

0.52 ± 0.01

0.05 ± 0.01

10 ± 1

10 ± 1

1.0

MTBR-R'

244

0.52 ± 0.01

0.76 ± 0.05

0.44 ± 0.05

9±1

9±1

1.0

PRR-MTBR-R'

149

0.72 ± 0.01

2.67 ± 0.63

2.72 ± 0.63

9±2

26 ± 9

2.9

PRR-MTBR-R' *

149

0.73 ± 0.01

2.41 ± 0.99

2.30 ± 0.99

10 ± 1

20 ± 6

2.0

PRR-MTBR

149

0.70 ± 0.01

2.61 ± 0.26

2.25 ± 0.26

11 ± 1

22 ± 2

2.0

2N-PRR

17

0.62 ± 0.01

0.76 ± 0.01

0.23 ± 0.01

8±1

8±1

1.0

0N-PRR

17

0.51 ± 0.02

0.71 ± 0.01

0.40 ± 0.01

8±1

7±1

0.9

2N-MTBR-R'

17

0.72 ± 0.01

0.72 ± 0.02

-0.01 ± 0.02

8±1

9±1

1.0

P1

149

0.32 ± 0.01

0.37 ± 0.01

0.16 ± 0.01

10 ± 1

10 ± 1

1.0

P2

244

0.32 ± 0.02

0.39 ± 0.02

0.21 ± 0.02

11 ± 2

12 ± 2

1.0

P2-MTBR

322

0.60 ± 0.01

1.37 ± 0.18

1.27 ± 0.18

10 ± 1

13 ± 2

1.3

P2-MTBR *

322

0.67 ± 0.06

0.89 ± 0.13

0.33 ± 0.13

11 ± 2

10 ± 1
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Table 3.3: Descriptive statistics of tau:tubulin
Resulting correlation curves from 15-25 nM tau was incubated with 10µM tubulin in
phosphate pH 7.4 at 20 °C were analyzed individually rather than averaged and fit to
describe the distribution within each dataset. Statistics of the diffusion times from select
tau constructs incubated with 10 µM tubulin without and with our filtering algorithm.
IQR and SD stand for interquartile range and standard deviation respectively. See
Appendix I.iii for details.
pre-filtering

post-filtering

τD (ms)

τD (ms)

construct

median

mean ± SD

IQR

# curves

median

mean ± SD

IQR

# curves

PRR-MTBR-R'

2.24

2.52 ± 1.41

0.99

394

2.02

2.06 ± 0.42

0.63

304

tau2N

1.35

1.43 ± 0.34

0.29

419

1.29

1.31 ± 0.12

0.23

327

tau2Nscr

1.48

1.79 ± 1.11

0.37

392

1.42

1.44 ± 0.15

0.20

301

tau1N

1.49

1.76 ± 0.96

0.59

578

1.31

1.33 ± 0.19

0.27

348

tau1N*

1.55

1.73 ± 1.31

0.40

424

1.50

1.51 ± 0.20

0.34

383

tau0N

1.61

1.80 ± 0.86

0.47

434

1.55

1.57 ± 0.25

0.36

378

Discussion
Since it was first isolated over 40 years ago (2), studies of tau have primarily
focused on the MTBR (1, 61, 63, 67, 72). My current study examines two domains of tau
that have been the subject of significantly less scrutiny: the NTD and the PRR. My
observation that the isolated PRR has the capacity to bind tubulin cooperatively and
polymerize microtubules in vitro, and that this function is negatively regulated by the
NTD, draws attention to the importance of these two domains in understanding tau
function.
The NTD has previously been shown to regulate the interaction of tau with
microtubules(63). Although not directly comparable to my results presented here with
soluble tubulin, prior work found that removal of the NTD increases the affinity of tau for
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microtubules (63). Moreover, in that work they observed that an NTD-lacking tau
fragment, was capable of bundling taxol-stabilized microtubules, whereas the comparable
construct including the NTD was not (63). This suggests a more promiscuous binding
interaction for stabilized microtubules in the absence of the NTD, consistent with our
observation for soluble tubulin (Fig. 3.2). Isoform dependent and electrostatic sensitive
regulation of microtubule bundling by the NTD is also cited in several more recent papers
(discussed in Chapter 2) (74, 91).
While I do not quantify the impact of the NTD on the affinity of tau for soluble
tubulin, I do find an inhibitory effect of the NTD in binding to soluble tubulin (Figs. 3.24). This inhibition seems to be due to the NTD as a whole, rather than resulting from the
absence or presence of a specific insert within the domain, as only small differences in
binding are observed for the tau0N, tau1N, tau1N* and tau2N variants when compared to a
variant lacking the NTD (Fig. 3.4). Insight into why the inserts do not have a significant
effect in regulating binding is gained from our smFRET measurements which show that
the relative dimensions corresponding to the NTD-PRR (tau17-244) or NTD-MTBR (tau17291

) are independent of the number of inserts (Chapter 2). This suggests that conserved

long-range interactions and/or conformational features of the NTD are important for
regulating interactions with tubulin, more so than the inserts themselves (Chapter 2).
Given that the NTD also significantly reduces the size and heterogeneity of ‘fuzzy’ tautubulin complexes (Figs. 3.3 and 3.4, and Table 3.3) (58), it follows that the NTD may
dynamically shield the weak tubulin binding sites distributed throughout the MTBR and
R' (Fig. 3.11). My results suggest this screening is a general function of the NTD that
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serves as an initial regulatory gate to tau-mediated polymerization, and is largely
independent of the individual N-terminal inserts.
Prior work from the Rhoades lab demonstrated a positive correlation between the
rate of tau-mediated tubulin polymerization and the size of tau:tubulin complexes by
systematically varying the number of tubulin binding sites in tau fragments (58). I find
that this observation broadly holds for the full-length isoforms and fragments studied here
in that PRR-MTBR-R' forms the largest tau:tubulin complexes and has shortest
polymerization lag-time (Fig. 3.5). My current work refines that model to include
controlling access to binding sites, and not simply the number of binding sites, as further
regulating the kinetics of tubulin polymerization. Consistent with this model are the
smFRET data that show that the interactions between the NTD and PRR/MTBR observed
in solution are lost upon tubulin binding (Chapter 2).
Our observation of assembly of tubulin by the isolated PRR was unexpected, as to
the best of my knowledge, there are no prior reports of this in the literature. NMR
chemical shifts suggesting binding were measured in the PRR of longer tau fragments in
the presence of MAP-stabilized tubulin constructs (65, 67). We also find tight, saturable
stoichiometric binding of 1:2 tau:tubulin dimers. Notably, PRR residues were not
observed in the recent cryo-EM structure of microtubule-bound tau (1). However, the
high-resolution structures shown in that study were obtained with tau fragments lacking
P1, which our results suggest is critical for tight binding of the PRR (Fig. 3.9). It may
also be that the PRR binds to a region unresolved within the structure, such as the
intrinsically disordered tubulin tails. Alternatively, it may be that the PRR mediates
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binding at low tau:tubulin ratios, such as the conditions of our experiments, but that it is
not associated with the microtubule lattice at the high tau:tubulin ratios required for cryoEM reconstructions.
The stoichiometric binding to soluble tubulin of the PRR provides a striking
contrast with the dynamic, heterogeneous ‘fuzzy’ tau-tubulin complexes formed when the
MTBR and R' were present in the constructs. In particular, tight and specific binding of
the PRR may offer an attractive target for therapeutic targeting relative to the
comparatively weak binding by the MTBR-R' (161). Interestingly, both P2 and R' were
identified relatively early as sequences important for productive tau-mediated
polymerization (67, 94). The ‘jaws’ model proposed that targeting of tau to the
microtubule lattice is through these regions, while the MTBR played a catalytic role in
assembly (64, 94, 95). Specifically, the introduction of either P2 or R' to the three-repeat
MTBR fragment enhanced binding to taxol-stabilized microtubules almost 10-fold, as
well as decreasing the polymerization lag-time by a factor of two (63). The presence of
both P2 and R' further enhanced the binding affinity and polymerization rate.
However, in my study, the PRR is the only isolated domain which demonstrates
any significant tubulin polymerization capacity; this is not seen for MTBR nor MTBR-R'
(Fig. 3.6B). This leads me to propose a variation to that model (Fig. 3.11). In my model,
the PRR serves as the core tubulin binding domain, binding to two tubulin dimers in a
critical step towards initiating polymerization. Multiple weak tubulin binding sites in the
MTBR and R' allow for increasing the local concentration of tubulin, resulting in
accelerated microtubule growth. The ubiquitous screening by the NTD of both the PRR
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and the MTBR serves as an initial gating that controls the size of these tau:tubulin
ensembles and, consequently, tubulin assembly. To clarify, within the global ensemble,
multiple microstates may exist, and tubulin may be bound to the MTBR-R’ prior to the
PRR. Additionally, conformational changes within the tau – specifically the NTD may
alter binding affinities between each site. In the below speculative model, P1, P2, R2, R3,
and R’ (ignoring the IR regions) are assumed to be the tightest binding regions.
Speculatively, the NTD may alter the affinity of one PRR site and two MTBR sites
resulting in a larger number of distinctive microstates in subclass C, but an over all
reduction in number of favorable tubulin-binding states. The microstate in which two
tubulin dimers are bound in the PRR (indicated by an arrow) in the E subclass is the
polymerization initiation favorable state. The MTBR-R’ region increases the number of
tubulin subunits bound. As these microstates are in equilibrium with the PRR microstate,
they also favor the probability of populating this polymerization-initiation favored
microstate.
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Figure 3.11: Model for regulation of tau:tubulin interactions
A) The PRR (orange) binds tubulin tightly and stoichiometrically, negatively regulated
by the NTD (blue). The MTBR-R' (red) increases the local tubulin concentration through
distributed, weak interactions, enhancing the polymerization capacity of tau. The Cterminus is colored black. Increasing both tau and tubulin concentrations favor
polymerization. B) Possible microstates in the first tubulin binding event to regions
within the PRR-MTBR-R’. Dark circles indicate favorable binding, and lighter colored
regions represent unfavorable binding. Two hypothetical subclasses ‘C1’ and ‘E1’
represent a closed and open formation for the NTD, respectively. These two subclasses,
and corresponding the microstates are all in equilibrium with each other. ‘T1’ indicates
one tubulin bound. C) Possible binding microstates upon the binding of a second tubulin.
Again, classes ‘C2’ and ‘E2’ represent a closed and open formation for the NTD,
respectively. The arrow indicates the microstate in which both tubulin dimers are bound
to the PRR region.
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Tau’s interactions with microtubules are regulated by phosphorylation (162) and
the majority of tau’s 40+ known phosphorylation sites are located in the PRR, including
those associated with Alzheimer’s disease (163, 164). Given this, perhaps the relative
importance of the PRR in both binding to and polymerizing tubulin should not be so
surprising. It has long been known that phosphorylation at serines 199 and 202 and
threonine 205 varies along growing axons (165). One very recent study reported a link
between phosphorylation of P2 and proper axonal localization of tau (166). However, the
relationship between phosphorylation and microtubule binding is not straightforward; to
illustrate, while phosphorylation of serine 214 and threonines 212 and 231 in the PRR, as
well as serine 262 in the MTBR, all lower the affinity of tau for microtubules, while
phosphorylation at other PRR sites has only a minor effect on microtubule binding (167).
How phosphorylation at any of these sites impacts binding to soluble tubulin has not yet
been tested. Moreover, the MTBR is also modified by lysine acetylation (163). Individual
or combinatorial effects of these modifications may alter both the binding affinity and the
stoichiometry of tubulin binding. There is a least one example of coordinated
modifications to tau in the literature: acetylation at lysines 280 and 281 within the MTBR
influences phosphorylation at serines 202 and 205 within the PRR (168). As a whole,
post-translational modifications may influence the interaction of the PRR or MTBR with
the NTD, suggesting that regulation of binding may be more complex than simply
reducing affinity and stoichiometry, but instead an intricate interplay between the NTD,
PRR and MTBR domains.
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CHAPTER 4: Biochemical and structural elucidation of the
core binding sites to soluble tubulin
Part of this chapter is adapted from Fung, H.Y.J., McKibben, K.M., Ramirez J.,
Gupta, K., and Rhoades E., “Structural characterization of tau in fuzzy tau:tubulin
complexes” (2020) 28(3) Structure doi:10.1016/j.str.2020.01.004. As one of the coauthors, I completed requested controls using fluorescence anisotropy to demonstrate the
labeling procedure and spectral shifts of the acrylodan data do not interfere with binding
(Appendix I.viii). Additionally, I contributed to the data interpretation regarding the
spectral shifts of acrylodan along the microtubule surface, and wrote the python code
used to analyze the FCS data. Another part of this chapter is adapted from Castle, B.,
McKibben K.M., Rhoades E., and Odde D., “Tau avoids the GTP cap at growing
microtubule plus ends” submitted. As one of the co-authors, I demonstrated tau’s GDPtubulin preference was unique to the microtubule lattice. I also provided all recombinant
protein for the study as well as requested controls. Regarding the unpublished work not
incorporated into the aforementioned papers within this chapter, Dr. Joyce Fung collected
the binding curve of PRR to tail-less tubulin.
Introduction
As previously discussed, the tau tubulin and microtubule interactions are broadly
assumed to be equal, although this has not been clearly demonstrated experimentally.
Indeed, the interactions with the MTBR are not equivalent – with R1 and R2 having a
higher affinity upon binding to microtubules, and R3 binding tighter to soluble tubulin
(62). There are two key differences between soluble tubulin and tubulin incorporated into
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the microtubule lattice that may influence these interactions. First, the ordered lattice may
occlude tau-binding regions or more simply unfavorably space the tau-binding regions.
Second, during GTP-dependent hydrolysis of the GTP-tubulin, there is a coupled
chemical (GDP is now bound) and conformational change within the tubulin. The
chemical identity of the GDP/GTP cofactor may impact tau binding. Alternatively, the
allosteric strain within the heterodimer along the lattice influence tau-tubulin interactions.
In this chapter, we present the potential impact of nucleotide and strain on tau binding to
the microtubule lattice as well as the preliminary investigations into tau-tubulin versus
tau-microtubule interactions.
Tau prefers GDP-tubulin within the lattice but is insensitive to nucleotide
state in solution
In some cases, MAPs may bind to the growing β(+) end of the microtubule such
as end binding protein 1 (EB1) which preferentially interacts with the GTP-cap. Tau is
also sensitive to the microtubule nucleotide state, and antagonizes EB1 in a
phosphorylation dependent manner (28). Yet, tau not exclusively associated with the end
of the microtubule but diffused across the length of the microtubule (47-49).
Unfortunately, these prior studies were in the presence of the drug paclitaxel, which has a
known influence on microtubule dynamics and tau-microtubule interactions. Therefore, a
more complete examination of tau’s potential tubulin nucleotide binding preference and
location along the microtubule is needed in the absence of drugs that influence
microtubule assembly.
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To map tau’s location along microtubules, fluorescently labeled tau2N was
incubated with microtubules grown from immobilized stabilized microtubules. Stable
microtubules that do not undergo microtubule dynamicity can be formed using a variety
of GTP analogs that are hydrolytically incompetent such as guanosine-5'-[(α,β)methyleno]triphosphate (GMPCPP). Short, stabilized fragments of microtubules are
termed microtubule seeds. Microtubule growth occurs when 1 mM GTP is added to
solution, and the GTP cap is hydrolyzed to GDP-tubulin; as the GTP cap is
comparatively small, the majority of the growing microtubule extension is GDP tubulin.
The GMPCPP-seeded region of the growing microtubule was composed of 15% labeled
rhodamine-tubulin, while the unstable, GTP-tubulin was only 5% labeled. This allowed
the two distinct regions to be easily quantified by brightness using total internal reflection
fluorescence microscopy (TIRF) (Figure 4.1A, B). Recombinant tau was labeled with
fluorophore AlexaFluor-488 (tau2N-A488). Two-color TIRF allowed for the localization
of tau along the immobilized microtubules. Clearly, tau2N-A488 prefers the GDP-tubulin
to the GMPCPP-tubulin seeds. This qualitative preferential binding between GDP-tubulin
and GMPCPP-tubulin was quantified by varying the amount of tau and measuring the
resulting binding (Figure 4.1C). We found nearly a ~5-fold increase in affinity between
GDP-tubulin and GMPCPP-tubulin rather than the nucleotide state itself.
As nucleotide state and tubulin conformation are coupled, we sought to determine
whether this preference was linked to the nucleotide itself or the conformational state of
tubulin in the GMPCPP or GDP bound state (169). To do this we used FCS to measure
the amount of tau2N-A488 bound as a function of the increase in diffusion time with
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increasing tubulin concentration. We incubated tau2N-A488 with GDP-tubulin and
GMPCPP-tubulin under non-polymerizing conditions and measured the diffusion time.
Unlike the dramatic difference seen in the microtubule lattice, we see no significant
preference between GDP-tubulin and GMPCPP-tubulin in solution. Preliminarily, this
suggests that the preference for GDP-tubulin versus GMPCPP-tubulin within the lattice is
a result of strain. It should be noted, that the two studies are not directly comparable due
to experimental restraints; however, the solution tubulin studies favor observable
differences between the two states given stronger tau-tubulin interactions within
phosphate buffer than BRB80 buffer used within the TIRF assay.
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7

Structural features of tubulin- and MT-bound tau are similar but not
identical
Prior work within the lab used an environmentally-sensitive fluorophore
acrylodan at specific points throughout tau’s MTBR repeat R3 to measure a periodic
pattern consistent with a helix when tau is bound to soluble tubulin heterodimer (160).
The higher resolution of the recently published cryo-EM structure suggested instead an
extended structure throughout the MTBR when bound to microtubules (1). This prompted
a re-examination of the previously proposed structure, as well as suggested there may be
structural differences between tau-tubulin interacting and tau-microtubule interactions.
Within this study, specific sites within the MTBR repeat R2 were labeled with
acrylodan of tau construct PRR-MTBR-R’ which contains all known binding sites to
soluble tubulin heterodimers or microtubules to date (Figure 4.2A). Site-specific labeling
with the MTBR does not impact binding of tau to tubulin (Appendix I.viii). Interestingly,
PRR-MTBR-R’ shows biphasic binding with the first plateau before ~2 µM tubulin
(Figure 4.2B). As described previously, PRR-MTBR-R’ forms large heterogeneous
complexes after ~1.5 µM tubulin (Chapter 3). These complexes are ‘fuzzy’– and
consequently highly dynamic and heterogeneous (58). Therefore, the complexes before
~2 µM tubulin represent lower occupancy complexes then those at higher concentrations
(Chapter 3, Figure 4.2B). As acrylodan spectral shifts are sensitive to the local chemical
environments surrounding the fluorophore, the degree of residue ‘burying’ when tau is
bound as well as the average occupancy of any binding site are averaged together (170).
To probe the chemical environment of both lower and higher-occupancy complexes, the
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acrylodan shifts were measured at both 2 µM and 10 µM tubulin. In all cases, the R2
residues showed a shift in fluorescence emission to lower wavelengths due to a reduction
in polarity of acrylodan’s surrounding environment upon binding (Appendix I.xvi).
However, the magnitudes of these shifts are both position and tubulin concentration
dependent (Figure 4.2D). For both 2 µM and 10 µM tubulin, there is an overall periodic
pattern that does not alter dramatically as more tubulin is bound (Figure 4.2D). This
suggests that a similar global ensemble exists for the lower and higher occupancy
structures, and the additional spectral shift indicates higher occupancy.
The periodic pattern of R2 is very similar to that within R3 – such that the peaks
and troughs align well at equivalent residue sites within the repeats. This suggests
equivalent tubulin-binding modes between the repeats. Generally, the shift in Δλmax at
each residue correlates positively with the surface accessibility (Å2) of the same residue
within the cryo-EM structure suggesting these two ensembles are similar (1). Where the
periodic pattern between of Δλmax and surface accessibility diverges (residues 292 – 297
in R2 and 323 – 328 for R3) is at the interdimer interface within the cyro-EM taumicrotubule structure, an unstable surface in soluble tau-tubulin structures.

8

86

Figure 4.2: Structure of tubulin- and MT-bound MTBR are similar
(A) Schematic of tau (residues 149 – 395) showing proline-rich region (PRR), MTbinding repeats (R1 – R4) and pseudo repeat (R') domains. Sequence alignment of R1 –
R4 is shown below with positions tested in orange. (B) Change in diffusion time (ΔτD) of
tauA488 upon tubulin binding. Data points are mean ± SD, n=3. Inset is magnification of
ΔτD for 0 – 3 µM tubulin. See Appendix I.iii for details. (C) Structural model of
tau:microtubule (PDB ID:6CVN) where tau is shown as orange cartoon and α(-)/β(+)tubulin as grey/light blue surfaces with their C-terminal residues highlighted in dark
grey/turquoise respectively (1). (D) Magnitude of emission shift (Δλmax) of tauacrylodan at
different positions in R2 in the presence of 2 or 10 µM tubulin. Data points are mean ±
SD, n≥3. See also Figure S2. (E) Δλmax in the presence of 2 µM tubulin plotted against
surface accessibility in tau:microtubule structure.

PRR and MTBR-R’ share binding sites
As previously mentioned, PRR binding was not seen in the recent cyro-EM
structure (Figure 4.2C), but prior NMR studies showed binding of a PRR-like construct
(amino acids 166-246) to both stathmin-complexed tubulin and taxol-stabilized
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microtubules with 1:2 stoichiometry (65). My work demonstrated PRR binding is tight,
and specific, and therefore qualitatively different from MTBR-R’ binding (Chapter 3).
One possible interpretation to resolve the differing structural models from cyro-EM and
NMR and the qualitative binding differences between the regions is that PRR and
MTBR-R’ may bind unique sites on tubulin. To test this, labeled PRR was incubated with
unlabeled tubulin prior to addition of unlabeled MTBR-R’. This was also tested with
labeled MTBR-R’ incubated with unlabeled tubulin prior to the addition of unlabeled
PRR. A decrease in diffusion time indicates a decrease in the number of the labeled tau
construct bound to tubulin. Surprisingly, both PRR and MTBR-R’ compete for soluble
tubulin with each other. PRR competes completely with MTBR-R’ as indicated by the
complete reduction in labeled MTBR-R’ diffusion time to what is expected for MTBR-R’
unbound in solution. However, MTBR-R’ does not completely compete with PRR within
the concentration range tested as indicated by the increased diffusion time of labeled PRR
from what is expected for unbound PRR. Due to the unknown stoichiometry of MTBRR’, we cannot determine which region is the stronger competitor or the type of
competition. Regardless, our preliminary data suggest PRR and MTBR-R’ either share at
least one binding site or are close enough to occlude each other.
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Figure 4.3: PRR and MTBR-R’ compete for soluble tubulin
The τD of labeled tau constructs PRR and MTBR-R’ bound to 1 µM soluble tubulin are
plotted against increasing competitor concentration (unlabeled PRR or MTBR-R’
respectively). The gray vertical dotted line represents the KD,app of PRR from Figure 3.6
(900 nM). The dotted horizontal lines are the τD for PRR or MTBR-R’ unbound and in the
presence of 1 µM tubulin without any unlabeled tau construct. Data are presented as
mean ± SD, n≥3 independent measurements. Measurements were carried out in
phosphate buffer pH 7.4 at 20 °C. See Appendix I.iii for details.

Disordered tubulin tails enhance tau binding
It has been suggested that C-terminal most helices H11 and H12 on the tubulin
dimers are required for tau binding (68). To the best of our knowledge, the available
structural and biochemical data prior to this thesis suggests P1 and R’ do not directly bind
the tubulin body (enzymatic chymotryptic digestion of tubulin binding sites (63, 65), and
the cryo-EM structure (1)). Additionally, it has been speculated that neutralization of the
negative charges on the tubulin tails results in microutubule polymerization (171). This
correlation in mutual binding sites between the polymerization-regulating regions of both
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tau and tubulin has significant implications, and therefore we sought to test the taildependence of PRR binding and R’.
In order to test the role of tubulin tails in tau-tubulin interactions, we digested the
tails using substilisin (Appendix I.ix). Matrix assisted laser desorption ionization time of
flight mass spectrometry (MALDI-TOF) analysis confirmed digestion of both ~ 1 KDa
tails from both α(-) and β(+) tubulin of the heterodimer (Fig. A1.4). As demonstrated by
FCS, there was nearly a 5-fold weaker affinity than intact tubulin. Furthermore, the
binding did not show bi-phasic characteristics. Importantly, treating the tubulin without
protease showed similar tau binding to untreated tubulin indicating the handling of
tubulin in this manner did not result in weakened binding. We then compared the binding
of PRR and MTBR-R’ to intact and tail-less tubulin using FCS. In both cases, the
binding of PRR and MTBR-R’ were reduced by upon loss of the tubulin tails. In the case
of MTBR-R’, binding was nearly lost. There is a similar dramatic decrease in binding to
tail-less tubulin when I tested the K16 (P2-MTBR) construct which lacks P1 and R’.
Unfortunately, due to weak binding of the MTBR construct alone to soluble tubulin, I
could not test the specificity of tail binding to the MTBR. Collectively the combination of
constructs tested suggests none of the proposed binding regions P1, P2, MTBR, or R’
bind uniquely to the tubulin tails.
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Figure 4.4 Disordered tails of tubulin enhance tau binding
Binding of tau constructs to intact tubulin, substilisin digested tubulin, and treated tubulin
as measured by an increase in τD as a function of tubulin concentration. Data are
presented as mean ± SD, n≥3 independent measurements. Measurements were carried out
in phosphate buffer pH 7.4 at 20 °C. Appendix I.iii for details of data analysis. (A) PRRMTBR-R’ binding to intact tubulin (black circle), digested tubulin (light gray circle), and
treated tubulin (dark gray diamond). (B) Binding of tau constructs (PRR = square;
MTBR-R’ = circle) to intact tubulin (solid color), substilisin digested tubulin (hollow
colored), and treated tubulin (solid gray). (C) Preliminary K16 (P2-MTBR) binding data
to tail-less and tailed tubulin (N=1).

The binding dependence on all tested tau constructs to the tubulin tails is curious.
It is possible there is no one specific region of tau that the tails bind, and the interaction is
largely non-specific electrostatic interactions between the positively charged tau binding
domains and the negatively charged tubulin tails. Alternatively, the interaction may be
‘fuzzy’ complex formation in which specific but heterogeneous interactions are forming
between the various binding regions on tau throughout the PRR-MTBR-R’ and the IDR
tubulin tails.
Tubulin come in a variety of isotypes (discussed in “Tubulin isotypes and the
‘tubulin code’”) which vary significantly in the C-terminal IDR tail. As IDR and IDP
interactions are governed primarily by the primary amino acid sequence (discussed in
“Intrinsically disordered proteins”), and each tubulin isotype is developmentally
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regulated, it suggests the tail region may have a functional origin. The specific isotype, in
theory, could influence the formation of the ‘fuzzy’ complex between tau and the IDR
tubulin tail due to differing amino acid composition between the tubulin isotypes. As the
sampling of PTMs in signal transduction is transient for IDPs, perhaps similarly, tau and
tubulin can ‘speak’ to each other through equivalent and matched biophysical
mechanisms. In this way, tau isoforms and the tubulin tail isotypes would interact
differentially. An underlying recognition mechanism is present, but it is disrupted or
enhanced by the specific tau isoform and tubulin isotype present resulting in differing
signals between the two proteins and cell-specific behavior. As a preliminary test of this
tubulin isotype-dependence of this theory, I designed helical bundles (H9-H12) through
the tubulin tails fused to MBP of the two most prevalent tubulin beta isotypes 4A and 2
(TubB4A and TubB2, respectively) within the bovine brain, and measured the binding of
PRR. Due to solubility issues, we could not test the binding of PRR to the helical bundles
alone for TubB4A, however, PRR does bind to the helical bundle of TubB2 alone.
Indeed, PRR alone shows a modest preference for TubB4A over TubB2. As there is little
difference in the length or overall predicted compaction of the tails, it is unlikely that a
non-specific fishing mechanism applies.
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Figure 4.5: Tau binds to helical bundle
(A) Alignment of TubB2 and Tub4A C-terminal tails. The green ‘E’ indicates the
polyglutamate PTM site on TubB2. (B) Binding of PRR to MBP fused TubB helical
bundles constructs 2 and 4A (MBP-TubB2HB and MBP-TubB4AHB respectively) as
measured by an increase in τnorm as a function of the respective tubulin helical bundle
concentrations (MBP-TubBHB). Data are presented as mean ± SD, n≥2 independent
measurements. Measurements were carried out in phosphate buffer pH 7.4 at 20 °C. See
Appendix I.iii for details of data analysis.

Discussion
Tau-tubulin and tau-microtubule interactions may differ from each other due to
tau binding site occlusion within the lattice, potential nucleotide preferences, as well as
strain and other spatial constraints along the lattice. Both our current work and prior work
(160) suggest that the MTBR repeats upon binding to soluble tubulin and microtubules
are similar, and interact with helices H11 and H12 on tubulin. However, it should be
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noted neither study resolved R4 or R’; therefore, speculatively either R4 or R’ interact
with the tubulin tails while R1, R2, and R3 interact predominately with the tubulin body.
The cyro-EM paper strongly suggests R4 also interacts with H11 and H12, although the
direct evidence of R4 within the full-length protein remains un-modeled due to low
resolution of the images (1). Interestingly, PRR still bound weakly, suggesting PRR binds
in part along the tubulin body. As resolved by the cryo-EM structure, polar residues
within the MTBR region also point outward speculatively toward the β(+)-tubulin tails
forming productive interactions (1). All the tested constructs within this brief study bound
weaker to tail-less tubulin than intact tubulin, and we cannot determine if there is a
specific region within tau that binds to the tubulin tails. Speculatively, it may be that the
unresolved regions simply have a preference for the tubulin tails over the tubulin body.
Similar to the variable affinities and preference within the MTBR for the lattice (R1 and
R2) and soluble tubulin (R3), tau binding to either the tubulin body or the tails is sampled
along all its potential binding regions throughout PRR-MTBR-R’, and PRR and R’ favor
tail-binding rather than along the tubulin body. The two tubulin binding hotspots (one on
the tails and one on the tubulin body) would then enforce the widely empirically
validated 1 tau : 2 tubulin stoichiometry (63, 69).
We have demonstrated lattice-dependent differences between full-length tau’s
preferences for GDP over GMPCPP tubulin despite significant structural similarities
between the tau-tubulin and tau-microtubule assemblies within the MTBR. Despite the
markedly different binding behavior of PRR and MTBR-R’, they share similar binding
sites and tail-dependent behavior. Strain/nucleotide state, tubulin isotype, PTMs on either
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tau or tubulin, and the tau isoform (NTD or MTBR) would then influence the preferential
binding towards a more specific tau region and consequently its unique structural and
functional characteristics. Therefore, tau-tubulin and tau-microtubule interactions may be
emergent properties of the tau global ensemble coupled to the tubulin code (both strain
along the tubulin body sensed through the helices H11 and H12 and patterning of isotype
and PTMs on the tubulin tails).

CHAPTER 5: Conclusions and Perspectives
My work within this thesis: (1) identifies PRR as an independent binding site to
soluble tubulin with polymerization capacity thereby expanding the currently described
tau-tubulin binding interactions and adds additional preliminary insight into comparing
tau-tubulin and tau-microtubule interactions, (2) demonstrates tau’s conserved
NTD/PRR/MTBR conformational ensemble, and finally (3) uses this biochemical
information to refine current tau-mediated polymerization models. Collectively, the work
within this thesis develops a model that focuses on tau’s interdomain interactions and
functions, and expands tau’s functional complexity by further coupling these binding
interactions to the tubulin ‘code’.
(1) PRR versus MTBR binding: expanding functional tau binding sites to
soluble tubulin
Frequently, it is broadly assumed that tau-tubulin and tau-microtubule interactions
are homologous. However, the tubulin lattice is a tube of alternating α(-) and β(+)
subunits lined end-to-end and zippered up. This results in a steric-driven system. There
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may be potential binding sites accessible only when tubulin is unincorporated. For
example, the heterodimeric α(-) end that is buried within the lattice or the side of the
tubulin would be oriented toward the lumen once incorporated into the microtubule
lattice may be potential tau-binding sites in solution. Furthermore, tau’s interactions with
the microtubule are largely driven by electrostatics (55-59). Therefore, if the tubulin
dimer is conformationally strained resulting in a deformation of the electrostatic field on
its surface, tau would potentially be sensitive to this ‘warped’ tubulin binding region.
Consequently, differences in binding site occlusion or even lattice strain may influence
soluble tau-tubulin interactions in different ways from the higher-order and constrained
tubulin structures. The Rhoades group tests this assumption directly. Prior work within
the lab has demonstrated that tau may bind to tubulin tighter than to microtubules (62).
Similarly, there are differences in hierarchal binding affinity within the MTBR repeats
between microtubules and tubulin (119, 160). To the best of my knowledge, the work
presented here represents the first systematic domain-centric search of tau-tubulin
interactions beyond the MTBR to soluble unincorporated tubulin without additional
stabilizing tubulin binding partners such as stathmin-like proteins. This led to the
surprising observation of PRR cooperative binding to soluble tubulin that was
comparatively tight and specific in comparison to the isolated MTBR-R’ which exhibited
weaker binding. Although P2 has long been indirectly associated with tubulin binding
and polymerization (63-65, 94), P1 has been missing from most studies, yet it doubles
tau’s binding capacity to soluble tubulin heterodimers and binds tubulin independently.
Future work on tau-tubulin interactions and tau-mediated microtubule dynamics must
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include P1 to fully incorporate all binding sites. Although tau is frequently divided into
the ‘projection domain’ (NTD and P1) and the ‘binding domain’ (P2 and MTBR-R’)
these broad functional labels are misleading. As tau-tubulin and tau-microtubule
interactions are dominated by electrostatic interactions (55-59), terminology and
construct designs that emphasize the amino acid content of the tau regions are more
nuanced. This would separate tau into three major regions. In the middle, the positively
charged ‘core’ containing PRR-MTBR-R’ which is both binding and polymerization
competent. Flanking either side of the ‘core’ would be oppositely charged domains Cterminal tail, and the NTD that negatively regulates the formation of tau-tubulin assembly
and spaces microtubules.
Although the PRR is capable of binding both lattice-incorporated and
unincorporated soluble tubulin, it is beyond the scope of this thesis to fully describe this
interaction. As previously mentioned, the recent cryo-EM structure did not resolve the
PRR binding on the microtubule lattice. We have presented preliminary evidence that tau
binding is heavily regulated though the tubulin tails and exhibits lattice-specific binding
preference for GDP-tubulin over GMPCPP-tubulin. However, this tail-dependent binding
is not specific to the PRR, and our current data suggests this binding is not isolated to any
one region of tau. Furthermore, PRR and MTBR-R’ share binding sites on tubulin; as the
MTBR is structurally similar when bound to both unincorporated and incorporated
tubulin, this would suggest PRR in part mimics MTBR along the tubulin body. Although
the tubulin binding sites may be the same, the binding characteristics of the tau region
bound vary (compare PRR to MTBR-R’) and may prove functionally relevant in
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combination with either binding region on tubulin. For example, speculatively
PRR:tubulin tail interactions may favor microtubule growth in the labile region while
MTBR-R’:tubulin body interactions may favor microtubule ‘pausing’ or stability. Further
structural and biochemical work is needed to resolve PRR binding on the microtubule as
well as to soluble tubulin. Speculatively, there are two binding ‘hotspots.’ One binding
site is on the tubulin body where tau senses mechanical strain along the lattice or whether
the tubulin is incorporated into the lattice. The other binding site on the tails that can be
either rapidly modified using PTMs or more statically incorporated by tubulin isotype
overall regulating tau binding as well as tau-microtubule interactions with other cellular
partners.
(2) PRR binding and NTD negative regulation: refining polymerization
models
Prior work from the lab focused on the functional relevance of ‘fuzzy’ complex
formation derived from the number of MTBR-R’ binding sites (58). In this model, the
dynamics of tau on the tubulin surface favorably increases the number and size of
tau:tubulin complexes. This ‘fuzzy’ complex formation is a dynamic binding property
that impacts tau-tubulin interactions in addition to the number of binding sites within tau
and their relative affinities to tubulin. In other words, this model added an additional
heterogeneous, structural component to the basis of tau-mediated polymerization ‘jaws’
model (64, 94, 95) that focuses on primarily on binding affinity and the number of
binding sites. The benefit of this view stems from tau’s potential to transiently sample
several binding regions on tubulin through multiple different binding sites within the
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PRR-MTBR-R’ (1, 172). I have found the NTD enforces an upper limit on the size of the
tau:tubulin complexes and the number of tubulin bound within the these large assemblies.
This negative regulation results in a ‘upper limit’ of the extent of tau-tubulin complex
formation. Perhaps most interesting is the lack of heterogeneous complex formation when
PRR is bound to tubulin, suggesting the initial tubulin binding and microtubule ‘seeding’
step is accelerated by the multiple binding-sites within the MTBR-R’ in a concentrationdependent manner. Therefore, the PRR acts as an initiating clamp flanked by a positive
regulator (MTBR-R’) and a negative regulator (NTD). Together, these two findings
present a refinement to prior tau-mediated polymerization models (58).
Coupling this polymerization model with the conserved NTD/PRR/MTBR
conformational ensemble, the specific combination of PRR and MTBR-R’ binding sites
filled may be transiently sampled and therefore influenced by the NTD domain. With this
view, although the isoforms may not necessarily have dramatically different binding
affinities to either soluble tubulin or microtubules, there may be differences in how these
isoforms function in the initial polymerization steps. The interactions between these
domains would tip the polymerization capacity of tau to an overall positive or
neutral/stabilizing state depending on which domain was dominating the tau structural
ensemble. This could be influenced by salt, tau:tubulin concentration and ratio, the NTD
or MTBR isoform or PTMs.
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(3) NTD/PRR/MTBR conformational ensemble and combinatorial
consequences of tau isoform to tau function
To the best of our knowledge, presented within this thesis is the first structural
comparison of the NTD isoforms. Surprisingly, the conformational ensemble is
conserved. Functionally, the NTD serves to slow polymerization and reduce the number
of tau molecules bound. There are subtle differences between all NTD isoforms in the
global structural ensembles, the binding heterogeneity at saturation, and a small but
significant difference in polymerization of tau2N. However, these differences are not as
great as one would anticipate given the strict developmental control of expression and the
number of added amino acids between isoforms. Perhaps the uniform behavior of these
isoforms within an in vitro system is misleading as the developmental regulation of the
isoforms implies a dynamic and growing system that is difficult to recapitulate in vitro.
Speculatively, the conserved ensemble acts as a general template for tau interactions,
with each NTD/MTBR isoform being expressed and decorated with PTMs in both a
combinatorial (the precise isoforms and PTM present) and graded (the ratio of isoform
and expression level) manner to suit the diverse and rapidly changing demands of a
growing cell.
In summary: complexity in dynamic systems favors biological function
There are approximately 100 billion neurons with breath-taking specializations
varying in shape and size (173). Within differentiated cells, microtubule dynamics along
the axon may promote cargo pausing and encourage delivery to presynaptic sites (13).
Similarly, microtubule dynamics has recently been suggested to influence memory and
8

100

learning with misregulation resulting in several diseases, including Alzheimer’s disease
(174). Recent advancements in in situ imaging of microtubule dynamics are allowing for
the rapidly involving studies of microtubule dynamics in vivo (175). One such study
demonstrated that suppression of microtubule dynamics during differentiation leads to
muscle tissue dysfunction in Caenorhabditis elegans thereby suggesting distinct sets of
MAPs are needed for tissue biogenesis and tissue function respectively (176). At the
same time, it has been suggested tau mRNA expression in neurons can encourage
differentiation in resistant or apoptotic sensitive cells (101), and increased tau expression
is associated with axonogenesis (177, 178). More specifically, one of the first biomarkers
of neuronal polarity is increased tau localization to the neurite that eventually turns into
the axon (178).
Salient features of tau are its functional role in neurodegenerative disorders and
microtubule dynamic instability, tightly developmentally regulated isoforms, and
promiscuous binding and cellular interactions. Tau can polymerize microtubules along
both polarities (builds from both the α(-) and β(+) end), phase separate and form
microtubule bundles in vitro (124), locate itself to the axon specifically through the PRR
in vivo (166), and potentially sense strain along the microtubule lattice. Two things an
injured football player and newborn baby have in common are severe head trauma and
differences in tau biology from ‘normal’ adult biomarkers (88, 97, 179). The
aforementioned links between (1) microtubule dynamics and neuron-specific
communication, (2) tau’s role in regulating microtubule dynamics, and (3) tau’s
association with axonogenesis and differentiation as well as loss-of-function disease
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mechanisms, lead to speculative theories that tau-tubulin/microtubule interactions play an
active role in both neuron differentiation and maintenance. Perhaps tau is involved in
maintaining axonal polarity in injured or differentiating cells? Or even more broadly,
perhaps tau is partially enforcing a particular regime of microtubule dynamics specific to
each cell or cellular compartment to establish or re-establish homeostatic functions?
Regulation of tau’s conformational ensemble would favor a subset of tau-mediated
cellular interactions over both long (isoform expression) and short (PTMs, environmental
sensitivity) time scales with the necessary sensitivity in complex cell signaling without
the need for novel regulatory cascades. In this way, tau-tubulin interactions are an
omnipresent regulatory mechanism, unlike the specific MAP subsets previously
suggested (176). For example, 0N3R may slightly favor TubB4A over TubB2, bind
tightly and overall enrich TubB2 within the microtubule lattice during axonogenesis.
However, during birth or a sudden injury, established neural networks may need those
connections reinforced in a non-specific manner. Continuing with my speculative
example, the corresponding PTMs to discourage 0N3R-microtubule binding would be
increased as well as PTMs to encourage 1N4R binding specifically along the new axon.
1N4R may have no preference for TubB4A over TubB2 and may increase the
concentration of both along the axon. Consequently, upon injury, the previously TubB2enriched axon becomes a more easily recognizable microtubule mosaic.
In this way, tau would mirror the influx of unincorporated tubulin and its changes
both along the lattice and within solution to produce the desired microtubule dynamics
for that particular cell given its current homeostatic, diseased/damaged, or growing state.
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Tau-tubulin/microtubule interactions would then have greater temporal resolution
through modifying PTMs. In this way, a unified and easily modified regulatory template
exists across all cells that are swayed simply by favoring certain tau:tubulin ensembles
without demanding novel protein factors with more specific regulatory sensitivity.
Robust development of the tau-mediated polymerization underpins critical assumptions
of this hypothesis, as it is dependent on balancing a variety of equilibriums between the
tau-tubulin binding sites and the tau regions themselves. As demonstrated in this thesis,
the PRR domain has different and unique behavior to the MTBR-R’ yet each full-length
isoform has a conserved ensemble which regulates both regions. How these tau regions
interact with each other and the combinatorial interplay between each region and their
respective isoform as a function of cellular environment, concentration, and interacting
tubulin ‘code’ presents a network problem with tau’s emergent property within a given
set of environmental conditions being defined primarily as a node of its collective
behavior throughout the cell. In other words, perhaps our diverging experimental
observations are simply an isolated subclass within the tau global ensemble with a
specific observable function and conformational ‘structure’.
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APPENDIX I: Experimental Procedures
i. Tubulin purification and handling
Tubulin was purified from fresh bovine brains as described in (146). Purified
tubulin was snap-frozen in BRB80 (80mM PIPES pH 6.8, 1mM MgCl2, 1mM EGTA).
Prior to use, frozen aliquots were rapidly thawed and then clarified at 100,000xg for 6
minutes. BioSpin 6 columns (BioRad) were used to buffer exchange tubulin into the
desired assay buffer. The tubulin absorbance at 280 nm was converted to concentration
using a molar extinction coefficient of 115,000 M-1cm-1. Tubulin was used within 2 hours
following clarification.
ii. Tau cloning, purification, and labeling
The parent tau plasmid encodes for longest tau isoform, tau2N. It includes an Nterminal His-tag with a tobacco etch virus (TEV) protease cleavage site for purification
(119). For site-specific fluorescent labeling, the native cysteines, C291 and C322, are
mutated to serine to allow for the introduction of cysteines at desired locations. Tau1N,
tau1N* and tau0N were generated using deletion cloning from the tau2N plasmid. The
nicked DNA fragments were fused using T4 DNA ligase (New England Biolabs) and T4
Polynucleotide kinase (New England Biolabs). The remaining tau fragments were
generated using either site-directed mutagenesis to introduce stop codons and cysteines,
deletion cloning of the remaining tau amino acids within the parent tau vector or a
combination of the two techniques.
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For the tau2Nscr construct, the Sequence Manipulation Suite at bioinformatics.org
was used to generate a series of random sequences based on residues 45-103,
corresponding to the N1 and N2 inserts. I chose the shuffled sequence that most closely
matched the distribution of hydrophobic and charged residues found in the wild-type
sequence without replicating the majority of that sequence. This oligonucleotide was
synthesized (Integrated DNA Technologies) with flanking nucleotides in the tau0N
(C291S C322S S433C) for splicing by overlap extension (111).
For all constructs (expect tau1N) longer than 200 residues, protein expression was
induced with 1mM IPTG at OD ~0.6 overnight at 16 °C. For constructs <200 residues,
tau protein expression was induced with 1 mM IPTG at OD ~0.8 for 4-5 hours at 37°C.
Tau1N constructs were induced with 1 mM IPTG at OD ~0.8 at 25 °C for 4-5 hours.
Purification was based on previously reported methods (119). Briefly, cells were lysed by
sonication, and the cell debris pelleted by centrifugation. The supernatant was incubated
with nickel-nitrilotriacetic acid resin (Ni-NTA) (Qiagen or BioRad) and the
recombination protein was bump eluted with 500 mM imidazole. The His-tag was
removed by incubation with lab purified tobacco etch virus (TEV) proteinase for either 4
hours at 20 °C (constructs <200 residues) or overnight at 4 °C (constructs >200 residues).
Uncleaved protein was removed by a second pass over the Ni-NTA column. Remaining
contaminants were removed using size exclusion chromatography on a HiLoad 16/600
Superdex 200 Column (GE LifeSciences) in Buffer C supplemented with 1 mM TCEP.
Proteins that did not require fluorescent labeling were buffer exchanged using Amicon
concentrators (Millipore) into the final assay buffer of interest, aliquoted and snap frozen
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for storage at -80 °C. Due to the small size and lack of aromatic residues, P1 and P2 were
TEV-cleaved as described above but after the fluorescent labeling (below). All other
proteins were labeled following elution from the size exclusion column.
All FRET and FCS measurements were carried out in constructs where both
native cysteines have been mutated to serine, C291/322S; for FRET, two additional
cysteines are introduced at desired locations as indicated in Table 2.1. For FCS, a single
cysteine is introduced as indicated in Table 3.2. Site specific labeling of tau for FRET or
FCS measurements was carried out as described previously (119). Briefly, tau was
incubated with 1 mM DTT for 30 minutes, and then buffer exchanged into labeling buffer
(20 mM Tris pH 7.4, 50 mM NaCl, and 6 M guanidine HCl). For FRET labeled
constructs, the donor fluorophore, Alexa Fluor 488 maleimide (Invitrogen), was added at
sub-stoichiometric ratios (0.3-0.5x), and incubated at room temperature for 15 minutes. A
3-fold molar excess of the acceptor fluorophore, Alexa Fluor 594 maleimide (Invitrogen)
was added and the reaction was incubated for another 10 minutes at room temperature,
and then moved to 4 °C for overnight incubation. For FCS labeled constructs, Alexa
Fluor 488 maleimide was added in 3-fold molar excess and incubated at room
temperature for 10 minutes, followed by overnight incubation at 4 °C. Labeling reactions
were protected from ambient light and with constant stirring; the dye was added
dropwise. For smaller constructs and tau1N, incubation for 1.5 hours at room temperature
instead of overnight at 4 °C was used on occasion. The labeled protein was buffer
exchanged into 20 mM Tris pH 7.4 and 50 mM NaCl and unreacted dye was removed
using HiTrap Desalting Columns (GE Life Sciences). Labeled protein was aliquoted and
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snap frozen for storage at -80°C. Cloned constructs were verified by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis.
iii. FCS instrument and data analysis
All FCS measurements were performed on our home built instrument, as
described previously (58). Prior to entering the inverted Olympus 1X-71 Microscope
(Olympus), the laser power was adjusted to ~ 5 µW (488 nm diode-pumped solid-state
laser, Spectra-Physics) and focused into the sample via a 60x water objective (Olympus).
Fluorescence emission from the sample was collected through the objective, separated
from excitation light by a Z488RDC long pass dichroic and a 500 nm long pass filter
(Chroma). The filtered emission was focused the aperture of a 50 µm diameter optical
fiber (OzOptics) coupled to an avalanche photodiode (Perkin-Elmer). A digital correlator
(FLEX03LQ-12, Correlator.com) generated the autocorrelation curves.
Measurements were made in 8-chamber Nunc coverslips (Thermo-Fisher)
passivated by incubation with (ethylene glycol)poly(L-lysine) (PEG-PLL)(62). The
labeled tau (15-25 nM) and tubulin (concentrations vary) were incubated in chambers for
5 minutes prior to measurement. Unless otherwise noted, all FCS experiments were
carried out in phosphate buffer pH 7.4 (20 mM phosphate, 20 mM KCl, 1 mM MgCl2,
0.5 mM EGTA, 1 mM DTT) at 20 °C. Multiple (20-40) 10 second autocorrelation curves
were collected per sample and fit to a single-component 3D diffusion equation:

Eq. 2
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where G(τ) is the autocorrelation function as a function of time (τ), τD is the translational
diffusion time of the labeled molecules and N is the average number of fluorescent
species. For our instrument, the ratio of the radial to axial dimensions of the focal volume
(s) was determined to be 0.2 and consequently fixed for analysis. The recorded intensity
trace is divided by N to give counts per molecule (CPM) in kHz.
For some tau constructs, high tubulin concentrations (>1 µM) result in the
formation of large, bright species (Chapter 3). These species are not present in the traces
of protein in the absence of tubulin (Fig. 3.8). A prior study from our lab demonstrated
these species are tau:tubulin specific, electrostatically sensitive and reversible (58). For
P2-MTBR, increasing the KCl concentration in our phosphate buffer to 300 mM –
previously seen by NMR to disrupt interactions between the PRR and tubulin – results in
disassembly of the larger species (Table 3.2) (95). In the case of PRR-MTBR-R', these
species persist even at 300 mM KCl suggesting the binding is either tighter or has a more
hydrophobic character (Table 3.2).
The individual autocorrelation curves arising from these larger assemblies
disproportionally weight the averaged autocorrelation curves used in the analysis
described above (Table 3.3 and Fig. A1.1). Working under the premise that removal of
these outliers would allow for a more meaningful analysis of the majority tau:tubulin
complexes, we developed an algorithm to remove aberrant curves, broadly following the
approach we described previously (58). Individual autocorrelation curves were fit with
Eq. 2 and assessed the goodness of fit using least-squares X2 = [G(τ)fit – G(τ)raw]2 with a
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tolerance of X2 = 0.0001 for a consecutive run of 75 ms. In other words, if the fit deviated
beyond the X2 for more than 75 ms, the curve was discarded. This process removes
99.5% of curves that cannot be accurately fit using Eq. 2. The frequency of these aberrant
curves is ~3% (Fig. A1.1A).
Autocorrelation curves arising from larger assemblies that pass this initial
criterion still skew the data towards slower diffusion times (Table 3.3). Descriptive
statistics of these diffusion times are reported in Table 3.3 as ‘pre-filtering’. In some
cases, such as PRR-MTBR-R' the measured τD could be as large as ~14 ms and up to 4x
brighter than unbound tau (Fig. A1.1B,C). Although of potential interest in another
context, these species do not represent the majority of the tau:tubulin complexes of
interest here. These outliers were removed in an iterative fashion by testing the individual
curves using an Anderson-Darling statistical test for either a lognormal or normal
distribution. Diffusion times above or below the interquartile range were removed until a
stable population was reached and no more curves were removed from the dataset. We
did not: (1) enforce a lognormal or normal distribution on the data-set prior to outlier
removal; nor (2) continue or use outlier removal if the population is normal or lognormal
after testing. This iterative function is demonstrated for tau2N in the absence (Fig. A1.1D)
or presence of 10 µM tubulin (Fig. A1.1E). The initial iteration simply tests for normality
(seen by the straight line in Fig. A1.1D for a single iteration). This results the removal
approximately ~15-25% of curves that passed the initial goodness-of-fit filtering from the
data set (Table 3.3).
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The fit parameters from the individual filtered curves are presented as scatter box
plots throughout Chapter 3, and the descriptive statistics of these values across multiple

independent measurements are listed in Table 3.3. There is a general correlation showing
that tau:tubulin complexes with larger τDs also had larger CPMs, reflecting the presence
of multiple tau molecules in these assemblies (Fig. 3.3). In order to allow for
straightforward comparison between tau isoforms, we also averaged the filtered curves
from each independent measurement and fit the average curve with Eq. 2. These τD
values obtained from these fits are reported in Table 3.2 for saturating points, and are
graphed in figures with FCS binding curves.
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Tau constructs of different lengths have different diffusion times. To allow for
straightforward comparison of the extent of binding between the various constructs, the
diffusion times for each construct in the presence of tubulin
that of the construct in the absence of tubulin

were normalized to

as follows:

Eq. 3

iv. FRET instrument and analysis
FRET histograms where the protein signal was readily distinguishable from the
‘zero-peak’ (180), arising from imperfect labeling, were carried out on our lab built
instrument as described previously (119). The laser power is adjusted to ~30 µW (488nm
diode-pumped solid-state laser, Spectra-Physics) prior to entering the microscope. Donor
and acceptor photons were separated using a HQ585 long pass dichroic and further
selected with ET525/50M band pass and HQ600 long pass filters (Chroma). For each
path, the emission was focused onto the aperture of a 100 µm diameter optical fiber
(OzOptics) coupled to an avalanche photodiode (Perkin-Elmer). Time traces were
collected in 1 ms time bins for 1 hour. As described above, measurements were carried
out in PEG-PLL coated Nunc chambers with 20-40 pM labeled tau following 5 minutes
incubation with tubulin.
To differentiate photon bursts arising from transit of a labeled molecule from
background fluorescence, a photon count threshold of 30 counts/ms was applied. For
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each burst, ETeff calculated using a lab-based written software (MATLAB) according to
the following equation (181, 182):
Eq. 4
where Ia is the intensity of the acceptor photons and Id is the intensity of the donor
photons. Within our system, the bleed through of the donor channel into the acceptor
channel (β) and the difference in the total quantum efficiency of the system and
fluorophores (γ) were determined using Alexa Fluor 488 hydrazine (Invitrogen) and
Alexa Fluor 594 hydrazine (Invitrogen) and fixed for analysis. Due to variation in
instrument build and detector efficiency over the course of the study, β and γ were
regularly re-determined and checked with DNA standards of 10, 14, and 18 bases labeled
with Alexa Fluor 488 and Alexa Fluor 594 (Integrated DNA Technologies). The energy
efficiencies were then binned, and the histograms fit using a sum of Gaussians in Origin.
One Gaussian described the “zero-peak” (donor-only fluorescence) and the second peak
described donor and acceptor labeled protein (main peak fit listed in Table 2.1). In some
cases, the distribution was asymmetric (such as tau17-149). In these cases, three Gaussians
were used to fit the data. The Gaussian that fit the dominant peak is reported in Table 2.1.
At some of the labeling positions, the proteins gave rise to low energy
efficiencies with overlap with zero-peak, making it difficult to accurately determine the
peak ETeff for the protein sample. To separate donor-only labeled species from the low
energy, donor and acceptor labeled species, measurements were repeated on a
commercial MicroTime 200 time-resolved confocal microscope (Picoquant) using its
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pulsed interleaved excitation FRET (PIE-FRET) mode. The power of the excitation lasers
(485 nm and 562 nm) were matched ~30 µW at 40 MHz. The fluorescence emission was
focused through a 100 µm pinhole and collected by avalanche photodiode. Fluorescence
emission of the donor and acceptor fluorophores were separated using a HQ585 long pass
dichroic and further selected with ET525/50M band pass and HQ600 long pass filters.
SymphoTime 64 software was used to analyze the photon bursts to yield both the ETeff
and stoichiometry factors for each burst, using photon threshold, binning and
experimentally determined β and γ values as described previously. The binned
histograms were fit as described above.
v. Tubulin light scattering assay
Polymerization of soluble tubulin was measured by monitoring the increase in
scattered light at 340 nm. The tubulin was clarified as described above and buffer
exchanged in phosphate buffer at pH 6.9 (20 mM phosphate, 20 mM KCl, 1 mM MgCl2,
0.5 mM EGTA, 1 mM DTT) immediately prior to use. For polymerization reactions, 10
µM tubulin was incubated with 5 µM tau (for tau2N, tau1N, tau1N*, tau0N and PRR-MTBRR') or 10 µM tau (for PRR, 2N-PRR, MTBR and MTBR-R') for 2.5 minutes on ice prior
to the addition of 1 mM GTP. Immediately after the addition of GTP, the reaction was
transferred to a warmed cuvette and the reaction was monitored for 10 minutes at 37 °C
in a fluorometer (Fluorolog FL-1039/40, Horiba) with a photon counting module (SPEX
DM302, Horiba) with both excitation and emission wavelengths set to 340 nm.
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Following polymerization, the samples were quickly returned to 4 °C for 5 minutes; cold
depolymerization is evidence that the proteins are not aggregated.
The curves were normalized to account for account for day-to-day variability in
the lamp intensity and fit in Origin with:
Eq. 5

where y is the normalized fluorescence intensity, t is time, t1/2 is the polymerization halftime and dt is the time constant. The mean and standard deviation of the t1/2 values are
listed in Table 3.1. The plotted graphs represent the average of the normalized triplicate
with standard deviation. Curves with very little polymerization, were normalized to the
brightest intensity within the given day.
Polymerization assays were carried out both with wild-type constructs (containing
the native cysteines at residues 291 and 322) as well as with constructs that had been
designed for FCS measurements but had not been labeled (native cysteines at residues
291 and 322 mutated to serines with an additional cysteine mutation introduced for
labeling). For two tau constructs, I directly compared the polymerization kinetics of wildtype and the C291/322S mutants and found that within the resolution of the light
scattering assay, the curves are identical (Fig. A1.2). This indicates both that: (1) the
removal of the native cysteines does not impact the ability of tau to polymerize tubulin;
and (2) the introduction of a non-native cysteine for labeling purposed does not impact
the ability of tau to polymerize tubulin. Thus, for the data shown within the thesis in
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Figs. 3.5 and 3.6, the triplicate measurements often consist of both wild-type and
C291/322S variants. To illustrate, within one triplicate, one curve is obtained with wildtype tau while the other two are with the C291/322S mutant (or vice versa). Similarly, I
tested the polymerization competence of tau2N before and after labeling with Alexa Fluor
488. In this study, due to the reduced yield of labeled tau2N, the concentrations of tau and
tubulin were changed to 2 µM tau and 20 µM tubulin and carried out in BRB80 buffer.
Again, there is no significant difference between the two polymerization curves,
indicating that within the resolution of our assay, fluorescent labeling does not impact
tau-mediated polymerization.
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Figure S4:
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Figure A1.2: Neither FCS mutationsNormalized
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impact tubulin polymerization
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a function
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Materialsat
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Methods
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For polymerization reactions, 20 µM tubulin was incubated with 2 µM tau for 2.5
Data are presented as mean ± SD minutes
following
normalization,
n=3
independent
on ice prior to the addition of 1 mM GTP. The reaction was then transferred
to a warm cuvette at 37ºC. The arrow indicates cold depolymerization at 4ºC.
measurements. Arrows indicate depolymerization
at 4 °C. (A) The polymerization
kinetics for wild-type PRR-MTBR-R' and PRR-MTBR-R'T149C-C291/322S, the variant
created for site-specific labeling for FCS, are indistinguishable indicating that under the
conditions of our assay, removal of tau’s native cysteines and introduction of a new
cysteine does not impact tubulin polymerization. Likewise, the polymerization kinetics of
wild-type PRR and the variant created for site-specific labeling for FCS, PRRT149C, are
comparable. For these assays, 10 µM PRR or 5 µM PRR-MTBR-R’ were incubated with
10 µM tubulin in phosphate buffer pH 6.9 with 1 mM GTP at 37 °C. (B) The
polymerization kinetics for 2N4RT149C-C291/322S (unlabeled tau) and 2N4RT149C-C291/322S
labeled with AlexaFlexa-488 (Alexa-488 tau) are indistinguishable under the conditions
of our assay indicating dye does not impact tubulin polymerization. For these assays, 2
µM 2N4R was incubated with 20 µM tubulin in BRB80 with 1 mM GTP at 37 °C.

The polymerizations were carried out in phosphate buffer at pH 6.9 while the FCS
experiments were carried out at pH 7.4. This chosen primarily due to PRR solubility
issues at pH 7.4 in phosphate buffer at high concentrations as above ~ 7 µM PRR begins
to aggregate without glycerol present as indicated by increased absorbance signal at 340
nm. It has been suggested that tau binding is pH sensitive through histidine-mediated
binding located throughout its MTBR region (75). To test whether the polymerization
assay condition at pH 6.9 unfavorably biases polymerization of the MTBR-R’ region, I
measured the binding of fluorescently labeled PRR-MTBR-R’ to unlabeled tubulin using
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FCS. There is no significant difference in PRR-MTBR-R’ binding to soluble tubulin
between the two pH conditions indicating the polymerization conditions do not screen
MTBR-R’ polymerization.

pH
pH 7.4
7.4 (N≥3)
pH 6.9
6.8 (N=1)
pH

τD (ms)

3

2

1

0

5

10

tubulin (µM)

Figure A1.3: pH does not affect PRR-MTBR-R’ binding
The τD of PRR-MTBR-R’ is plotted against increasing tubulin concentration at two
different phosphate buffer pHs. Measurements were carried out in phosphate buffer at 20
°C. See Appendix I:iii for details of data analysis.

vi. Electron microscopy imaging
EM images were taken by Dr. Changsong Yang of the Svitkina group.

Polymerization reactions using PRR, 2N-MTBR-R’, and PRR-MTBR-R’ were
carried out and monitored as described above. After 10 minutes of polymerization at 37
°C, the sample was transferred to Cu-coated 200 mesh electron microscopy grids
(Electron Microscopy Sciences, FCF200-Cu) and incubated with 20 µM taxol on the grid
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for 1.5 minutes, as generally described in published protocols (183). The grids were
washed with BRB80 buffer to remove interfering phosphate salts and stained with 2%
uranyl acetate. Images were taken on a JEOL JEM-1011 transmission electron
microscope.
vii. Microtubule pelleting assay
Taxol stabilized microtubules were made by incubating ~65 µM clarified tubulin
with 4 µM taxol for 15 minutes at 37 °C. The taxol concentration was increased to 40 µM
and incubated for another 15 minutes. The polymerized microtubules were pelleted by
ultracentrifugation at 353,000xg for 20 minutes at 25 °C. The resulting pellet was
resuspended in phosphate buffer adjusted to pH 6.9. The concentration of the harvested
microtubules was determined by absorbance at 280 nm (ε=115,000 M-1cm-1) after cold
and chemical denaturation in 8 M urea at 4 °C. The taxol-stabilized microtubules were
diluted to 10 µM in phosphate buffer pH 6.9, and incubated with 1 µM Alexa Flour 488
labeled tau for 10 minutes at room temperature. The microtubules and associated tau
were pelleted by centrifugation at 353,000xg for 20 minutes. The pellet was resuspended
in an equal volume as the collected supernatant (70 µL) and cold denatured. Tau in the
absence of microtubules was subjected to the same assay as a control. Quantification of
microtubule binding was by SDS-PAGE; band intensity of Alexa Fluor 488 fluorescence
was analyzed using ImageJ. The gels were imaged using using Typhoon FLA 7000. Both
Alexa Fluor 488 fluorescence and Coomassie staining were recorded for the same gel.
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viii. Fluorescence anisotropy
Fluorescence emission of tauacrylodan and tau488 labelled at position T149 were
measured on a JASCO-8300 fluorometer with temperature control accessory ETC-815.
For tauacrylodan was excited at 390 nm and scanned from 400 to 600 nm. For tau488 was
excited at 470 nm and scanned from 480 to 650 nm. Both excitation and emission slits
were set to 2.5 nm. Clarified tubulin was buffer exchanged into phosphate buffer (20 mM
potassium phosphate pH 7.4, 20 mM KCl, 1 mM MgCl2, 0.5 mM EGTA, and 1 mM
DTT) and incubated at varying concentrations with 300 nM tau for 5 min prior to
measurement. Each spectra was integrated to overcome spectral shifts in acrylodan. The
anisotropy signal (r) was calculated according to Eq. 6:
Eq. 6
Where IVV, IVH, IHV, and IHH are the integrated intensities for each respective excitation
and emission polarizer position.
The normalized change in anisotropy (rnorm) is calculated by subtracting the
measured anisotropy signal subtracted from the unbound tau anisotropy signal and
dividing by the difference between the bound signal at 2 µM tubulin and the unbound
signal according to Eq. 7:
Eq. 7
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A1.4 Labeling positions or common dye sizes do not affect binding
Anisotropy (r, right and rnorm, left) of tau labeled with acrylodan at I277 and K281 or with
Alexa Fluor 488 at T149 titrated with tubulin. Data points are mean ± SD, n=2 – 3. Error
bars in normalized plot on the left are not error-propagated. The r of Alex Fluor 488 and
acrylodan differ, however, the binding curves are the same (rnorm) are comparable. As the
spectral shifts of acrylodan differ between I277 and K281, the spectral shift is not a
reflection of weakened binding due to point mutation and labeling, but rather the local
environment when bound.
ix. Tubulin tail digestion
Tailless tubulin was generated by modification of a published protocol (184).
Briefly, tubulin was quickly thawed and buffer exchanged into 1/10X MES buffer (0.1 M
MES pH 6.9, 1 mM MgCl2 and 1 mM EGTA) using Bio-spin 6 columns and diluted to 50
µM. GTP was added to 1 mM and the mixture was incubated at room temperature for 5
Figure S2. Related to Figure 1. Tau labeled with acrylodan binding to tubulin (A)
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kDa when compared to intact tubulin, consistent with the loss of tails from both α(-) and
β(+) subunits. Prior to use, aliquots of tailless tubulin were clarified and buffer exchanged
as described previously.

Figure A1.5: Digestion of tubulin tails
MALDI-TOF spectra of intact (upper) and tailless (lower) tubulin. The difference in mass
between intact and tailless tubulin is <2 kDa, consistent with the removal the disordered
tails from both tubulin monomers (184).

x. MBP-TubBHB Purification
The TubBHB genes for TubB4A (amino acids 310-444) and TubB2 (amino acids
310-445) were codon optimized for bacterial expression and synthesized by Genescript,
and then cloned into the pET His6 maltose binding protein (MBP) TEV ligation
independent cloning (LIC) vector (plasmid #29656) using traditional LIC techniques.
Alignment of the TubBHB component for MBP-TubB4A and MBP-TubB2 in Figure
A1.4.
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pET His6 MBP TEV cloning vector (1M) was a gift from Scott Gradia (Addgene plasmid
# 29656 ; http://n2t.net/addgene:29656 ; RRID:Addgene_29656)

Figure A1.6: Alignment of TubB helical bundles
Alignment of amino acid sequences of bovine TubB4A and TubB2 with secondary
structures highlighted and numbered according to PDB 1JFF (185). Blue highlighted
regions indicate β-sheets and red regions indicate α-helices.
The MBP-TubBHB constructs were induced with 500 µM IPTG at OD ~0.6 at 25
°C overnight in LB media. The collected pellet was resuspended in Ni-Buffer A
supplemented with 2 mg/ml lysozyme and 1 EDTA-free cOmplete inhibitor cocktail
tablet and stored at -80 °C. Cells were lysed by sonication, and the cell debris pelleted by
centrifugation. The supernatant was incubated with nickel-nitrilotriacetic acid resin (NiNTA) (Qiagen or BioRad) and the recombination protein was bump eluted with 500 mM
imidazole. Remaining contaminants were removed using size exclusion chromatography
8
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on a HiLoad 16/600 Superdex 200 Column (GE LifeSciences) in Buffer C (25 mM Tris
pH 8.0, 100 mM NaCl) supplemented with fresh 1 mM TCEP.
xi. TubBHB Purification
The TubB2 plasmid encodes for an N-terminal His-tag with a TEV protease
cleavage site for purification. TubB2 were induced with 1 mM IPTG at OD ~0.8 at 37 °C
for 3.5 hours in unsupplemented terrific broth media. The collected pellet was
resuspended in BRB80 supplemented with 10 mM imidazole and 50 mM NaCl, 2 mg/ml
lysozyme, and 1 EDTA-free cOmplete inhibitor cocktail tablet and stored at -80 °C. Cells
were lysed by sonication, and the cell debris pelleted by centrifugation. The supernatant
was incubated with Ni-NTA resin (Qiagen or BioRad) and the recombination protein was
bump eluted with 500 mM imidazole. The His-tag was removed by incubation with lab
purified TEV proteinase for 2.5 hours at 20 °C. Uncleaved protein was removed by a
second pass over the Ni-NTA column. Remaining contaminants were removed using size
exclusion chromatography on a HiLoad 16/600 Superdex 200 Column (GE LifeSciences)
in Buffer C supplemented with fresh 1 mM TCEP.
xii. CD Spectroscopy
Circular dichroism (CD) confirmed helical structure of the tubulin bundles.
Spectra were taken in 20mM phosphate buffer pH 7.4. The measured CD signal (θobs(λ))
was converted to molar ellipticity ([θ]) using Eq. 8:
Eq. 8
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where npb is the number of peptide bonds (number of amino acids – 1), l is the pathlength
and c is the concentration.

Figure A1.7: Purified TubBHB constructs are predominately helical
All tested constructs form predominately helical bundles as indicated by characteristic
negative molar ellipticity ([Θ] deg⋅cm2⋅dmol-1) at ~ 195 nm and ~ 225 nm as measured by
CD.

xiii. Preparation and functionalization of imaging chambers
Slide preparations were performed by Dr. Brian Castle of the Odde group.
Imaging chambers for TIRF microscopy were assembled and functionalized as
described in (186), with few modifications. First, an acid cleaned coverslip was rendered
hydrophobic by brief incubation in Rain-X® Original Glass Water Repellent (ITW
Global Brands, Houston TX) at room temperature (187). Coverslips were then allowed
to dry completely before remaining residue was wiped away using lens paper.
Hydrophobic coverslips were then mounted to acid cleaned glass slides using double
sided tape, forming three separate imaging channels.
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Imaging chambers were functionalized by flowing in solutions of 0.1 mg/mL
NeutrAvidin (ThermoFischer Scientific, Waltham, MA) in PBS, followed by 5%
Pluronic® F-127 (Sigma-Aldrich, St. Louis, MO) in PBS, and then doubly stabilized
GMPCPP microtubule seeds (5% or 15% rhodamine-labeled, 5% biotin-labeled) in
BRB80 (80 mM PIPES/KOH pH 6.9, 1 mM EGTA, 1 mM MgCl2). For each separate
solution, chambers were allowed to incubate at room temperature for 10 mins and then
washed with 8-10x chamber volume of BRB80. After the last wash, 2x chamber volumes
of the imaging solution was flowed through the imaging chamber before moving to the
microscope for imaging.

Imaging solution consisted of indicated concentration of

porcine brain tubulin (5% or 15% rhodamine-labeled, Cytoskeleton Inc., Denver CO) and
Alexa488-labeled tau in BRB80 supplemented with 1 mM GTP, 40 mM D-glucose, 8
µg/mL catalase, 20 µg/mL glucose-oxidase, and 0.1 mg/mL casein. To prevent sample
drying during imaging, individual imaging chambers were sealed using CoverGrip
sealant (Biotium, Fremont, CA).
xiv. TIRF microscopy
TIRF microscopy experiments were performed by Dr. Brian Castle of the Odde group.
Unless otherwise noted, all proteins were handled and stored as described
previously(186). Rhodamine-labeled microtubules growing from double-stabilized
GMPCPP microtubule seeds were imaged by TIRF microscopy using a 100x, 1.49NA
Apo TIRF objective on a Nikon TiE inverted stand equipped with the Perfect Focus, HTIRF module and LU-N3 laser launch (Nikon Instruments Inc., Melville, NY) under
control of NIS-Elements software (v4.xx, Nikon Instruments). Images were collected on
a Zyla 4.2 PLUS sCMOS camera (Andor, Belfast, UK) with a high speed emission filter
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wheel (HS-632; Finger Lakes Instrumentation, Lima, NY) placed between the camera
and stand for color separation. Additional 1.5x tube lens in the microscope stand resulted
in a total magnification of 150x (42 nm/pixel).

For tau binding and microtubule

dynamics imaging, 488 nm and 561 nm TIRF lasers were reflected up through the rear
aperture of the objective using a triple band pass filter set (TRF69901; Chroma
Technology Corp., Bellows Falls, VT).

Unless otherwise noted, all images were

collected using 200 ms exposure at 20% laser power. For FRAP experiments, a 488 nm
100 mW Argon-ion laser (Spectra-Physics, Santa Clara, CA) shuttered by a Uniblitz
VS35 shutter (Vincent Associates, Rochester, NY) was focused on the imaging plane as
previously described using a separate light path from that used for TIRF imaging (188).
Bleach event timing was set to a 3 s delay and 100 ms exposure using a VMM-TI shutter
driver/timer (Vincent Associates). Simultaneous TIRF imaging was accomplished by
replacing the triple band pass filter above with an 80/20 beam splitter. To compensate for
the beam splitter, the 488 nm TIRF laser was increased to 100% power such that 20%
laser power used for imaging was maintained. Temperature was maintained at 37°C
using an objective heater (OkoLab S.R.L., Pozzuoli, Italy) and airstream incubator
(Nevtek, Burnsville, VA).
xv. Microtubule tip tracking and fluorescence profile analysis
Microtubule fluorescence analysis was performed by Dr. Brian Castle of the Odde group.
The dynamic microtubule end was tracked using our previously described semiautomated algorithm, TipTracker (version 3.1), without modification (189, 190). Briefly,
fluorescence profiles along the determined microtubule axis (x’’-axis) are fit with a
Gaussian survival function (Eq. 9):
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Eq. 9
where µPF is taken to be the position of the microtubule tip, IMT and IBG are the
fluorescence intensity on the microtubule and the background, respectively, and σPF+PSF is
the spread of the fluorescence due to the combination of the point spread function and the
taper or spread of protofilament lengths at the microtubule tip. For averaging purposes,
fluorescence profiles along the microtubule axis from all channels (tubulin, tau, and EB1)
were aligned to µPF determined from the tubulin channel (either rhodamine-tubulin or
mCherry-α-tubulin). Fluorescence offset values were the difference between µPF resulting
from tracking the tubulin and tau channels (offset = µPF,tub – µPF,tau). In vitro fluorescence
profiles were normalized to the maximum value while in vivo profiles were normalized to
an average of the first 10 values.

xvi. Acrylodan labeling
Tau construct purification and acrylodan labeling was carried out by Dr. Ho Yee Joyce
Fung in the adapted figures within this thesis. Jennifer Rameriez and myself purified
additional constructs for other figures within the published paper (142). Jennifer
Rameriez labeled those constructs.
For labeling, the proteins were concentrated to ~300 µM (ελ=280nm= 4470) and
treated with 1 mM DTT for 30 mins at room temperature to reduce the cysteines. The
proteins were then buffer exchanged into Buffer E (20 mM Tris pH 7.4, 50 mM NaCl)
with 6 M guanidine HCl using HiTrap desalting columns. For Alexa Fluor 488 labeling,
the C5 maleimide dye in a DMSO stock was added in 2 – 4 times molar excess and
incubated at room temperature for 30 mins followed by overnight incubation at 4°C. For
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acrylodan labeling, DMSO was added to the protein sample to 10% final concentration
prior to the addition of dye to 4 times molar excess and incubated for 4 hrs at room
temperature. In both cases unconjugated dye and guanidine HCl was removed from the
protein samples by two rounds of buffer exchange into Buffer E using concentrators and
a final desalting column step. Labeled proteins were aliquoted, snap frozen and stored at 80°C until use. Complete labeling of tau proteins were confirmed by MALDI-TOF mass
spectrometry using a Bruker Ultraflex III instrument. Sinapic acid dissolved in 50:50
acetonitrile:water (v/v) and 0.1% TFA was used as a matrix.
xvii. Acrylodan fluorescence
Acrylodan measurements were performed by Dr. Ho Yee Joyce Fung.
Fluorescence emission of tauacrylodan was measured using a Horiba Fluorolog-3
fluorometer in a Quartz cuvette. Excitation was set at 390 nm and emission was scanned
from 400 to 600 nm. Both excitation and emission slit widths were set at 2 nm. The
cuvette holder was held at 20°C. 300 nM tauacrylodan was mixed with varying tubulin
concentrations in Buffer F and incubated in an eppendorf tube for 5 mins prior to
measurement. Either 3 or 4 independent measurements were made for each tau construct
using different tubulin aliquots across multiple days.
xviii. Analysis of acrylodan emission peak shifts
Acrylodan analysis was performed by Dr. Ho Yee Joyce Fung.
Each emission trace was background subtracted with buffer or tubulin only
measurements. Maximum emission wavelength was determined using Origin peak search
algorithm using 1st derivative method with smoothing. For each labeling position,
measurements were made of tau in the absence and presence of tubulin and the mean
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emission maximum of tau in the absence of tubulin was used to calculate the shift in the
emission peak, Δλmax. The emission maximum for tau labeled with acrylodan in the
absence of tubulin was relatively insensitive to position, with peaks ~522 nm (Figure
A1.7). The emission peaks shifts are reported as means and standard deviations. The error
is propagated in the calculations for changes in peak shifts. In Figure 3B and C,
normalization was performed using the measured peak shift at 10 µM tubulin and the
standard deviation was error-propagated. Data were plotted using Origin and the
accompanying structure figure (Figure 4.2) was generated using Pymol. Surface
accessibility of residues in Figure 4.2 was calculated using GetArea (191).

Figure A1.8: Raw acrylodan data
(A) Emission spectra of tau acrylodan in all positions tested in this study. Intensities are
normalized to peak maximum for comparison. Peak emission was not affected by
location of acrylodan conjugation. (B) Representative plots of emission blue-shifting
(Δλmax) of tau acrylodan (at K281) in the presence of 2 µM and 10 µM tubulin.
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APPENDIX II: FCS Python code
The original code developed to analyze FCS data was written in MATLAB and
required curves to be discarded ‘by eye’ prior to weighting and fitting the data. The
individual curves were analyzed by a separate program that imposed a Gaussian over the
data and removed any curves outside of this distribution. Again, the goodness of fit of
each curve was not assessed but was handled at the user’s discretion. In the case of the
later program, it was developed to analyze K16 data – which suggests only one tau is
bound at 10 µM tubulin – and therefore discarded up to 70% of the PRR-MTBR and
PRR-MTBR-R’ data sets. To correct for the redundant problem of biased datasets
towards smaller species and user dependent curve filtering, I wrote a new program using
Python which analyzes all the desired information without user input. The parameters and
additional description are listed in Appendix 1.iii. I would like to thank Joshua
Straquadine for helpful advice and assistance in the development of this program.
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